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In this work, interaction and bond properties of anticancer drug doxorubicin (DOX), (6,6) armchair 
single-walled carbon nanotube (SWCNT), and hydroxyl- and carboxyl-functionalized SWCNT (ƒ-
SWCNT) have been investigated based on DFT theory to design, improve and expand carbon nanotube 
(CNT) drug carriers for any biomedical system. Geometrical, structural, electrical, bonding and 
thermodynamic properties as well as equilibrium distances, adsorption energies, quantum molecular 
descriptors and frontier molecular orbitals or different drug arrangements on CNT at the highest 
equilibrium at WB97XD/6-31+G (d, p) level of theory at aqueous and gas phases were explored. Our 
calculations showed that hydrogen bonds between active sites of the spontaneous adsorption of 
doxorubicin )DOX( molecule and hydroxyl- and carboxyl-functionalized CNTs played a more important 
role than those with pristine CNTs in the adsorption and fixation of the studied complexes. Using 
quantum theory of atoms in molecules (QTAIMs) method, intermolecular interactions and 
corresponding descriptors at critical bonding points in aqueous and gas phases were also investigated. 
Evaluation of the results obtained from the natural bond orbital (NBO) analysis showed that the direction 
of electron movement was generally from drug molecule to CNT. 
Also, we investigated the effect of mechanical properties of CNT on doxorubicin drug molecule 
adsorption and encapsulation capability inside its cavity. Recently, nanostructures have become popular 
as carriers in drug delivery system due to their smaller particle sizes, drug molecule protection, and slow 
and controllable release of drugs. This study aims to investigate the effects of the mechanical properties 
and thermal conditions on DOX molecules into the inside and onto the surface of CNTs by using 
quantum calculations and molecular dynamic simulations. First, NBO method was used to obtain the 
electrical charges of atoms in an aqueous solution. Secondly, molecular dynamic simulations (MD) were 
used to investigate 10 different systems with different properties. Based on the obtained results, it was 
suggested that doxorubicin molecules were spontaneously adsorbed toward CNT. By analyzing and 
comparing the variations of Van der Waals (VdW), electrostatic energies (EL), number of contacts 
between the drug molecules and CNTs and radial distribution function it was found that the variations 
of mechanical properties of CNTs, as well as the temperature conditions of environment, significantly 
affected the efficiency of spontaneous adsorption of doxorubicin toward the surface and inside CNTs. 
Furthermore, to design and develop as well as to investigate how the SWCNT and DOX complex enter 
the cell membrane in the presence and absence of ethanol molecules, a steered molecular dynamic 
simulation performed to show the relationship and interactions between drug molecules and CNT along 
the penetrated into the lipid bilayer. We investigated the stability of DOX molecules inside nanotubes 
in presence and absence of ethanol molecules. We conclude that in the presence of ethanol molecules in 
extracellular, more pulling force as well as more time is required for the DOX and CNT complex to 
penetrate the cell membrane. It was also observed that due to the spontaneous encapsulation of ethanol 
molecules into the nanotube, the adhesion of DOX molecules to the inner surface of the CNT is reducsed 
and the possibility of its separation has been increased. 
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1. 1. Background 
Drug delivery systems (DDS) use different methods and substances to deliver drugs to the target tissues, 
organs, cells, organs, and release drugs by various drug carriers. Historically, the first method used by 
humans to inject medicine into the body was to chew and eat the roots and leaves of medicinal plants, 
then the method of steaming or breathing smoke from burning was used. Also, later, by identifying the 
medicinal properties of plants and animals, they used their extracts. Although these initial methods were 
useful, they had shortcomings such as non-uniformity, consistency and accuracy. Controlled use of the 
drug dates back to 1000 years ago, when two Persian alchemists, Ibn Sina (980-1037) and Zakaria Razi 
(865-925), first proposed coating the surface of tablets with mucilage with the addition of silver-plated 
coating and psyllium, respectively. Although they were aimed to change the pungent taste of pills, 
overall, the coating changed the rate at which the drug was released. Pearl coating was another technique 
used to coat the composition of talc-mucilage tablets, which resembled pearls, and was used in the 11th 
and 12th centuries. Between the 1940s and 1950s, the first intermittently coated pills, called sustained 
release products, were invented that had the ability to release periodically. In the meantime, the duration 
of action of the drug increased and the dose decreased [1]. 
In 1952, SmithKline Beecham introduced the first Spansules® tablet with a predetermined-release 
formulation that sustain dextroamphetamine sulfate (Dexedrine®) release kinetics up to 12 hr, which at 
the time had controlled release capability limited to coating pills. He then divided the controlled drug 
delivery system into three generations. The first generation began with the introduction of spansul 
capsules containing a great number of micro-pellets with water-soluble wax coatings of various 
thicknesses. This never led to gradual drug release for up to 12 hours, which scientists later introduced 
various mechanisms for the release of the drug, such as (osmosis-, diffusion-, dissolution-,  and ion-
exchange-controlled mechanisms) And they succeeded in developing it [2]. 
Although DDSs were significantly developed from 1980s to 2010, which is related to the second 
generation of DDSs, there has been no significant success in providing clinical formulations [3]. After 
10 years of extensive investigation, it was found that zero-order release kinetics did not necessarily need 
to be classified as controlled release DDS because it could not keep the drug concentration constant and 
its release depended on located in the gastrointestinal tract and intestines at different pH, which was 
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unpredictable [4]. It was during this period that intelligent hydrogels and polymers were developed, 
which were characterized by their sensitivity to the environment, such as changes in factors to the 
surface. pH, temperature, electricity and light and etc [5]. In the last 10 years of the second DDS 
generation, scientists have focused on developing nanotechnology-based targeted DDS for tumors, as 
well as gene and drug delivery. They used biodegradable polymers in the structures of nanoparticles, 
nanotubes, lipids, chitosan and dendrimers. The researchers tried to use these nanoparticles to enhance 
releasing drugs in target points with the help of blood stream. 
The main problem of the second-generation of DDS is the lack of sufficient understanding of the 
influences of using this method on human body and inability to solve biological problems by changing 
the physicochemical characteristics of DDSs. Therefore, to overcome these problems in the new DDS 
generation (3rd generation) more pharmaceutical research is done and different disciplines are used to 
expand these systems, for example, materials science, engineering, physics and mechanics, biology, 
physiology and computer science. In this generation, most studies are to identify the exact effects of the 
use of new substances on the biological and physicochemical characteristics of human body. 
Physicochemical problems related to low drug solubility in water, which causes drugs to accumulate 
and precipitate, which exacerbates toxic effects, and the problem of controlling drug release kinetics [6]. 
The design of nanocarriers by nanoparticles for DDS is of great importance to overcome these problems, 
which has been the subject of much research by researchers in the last decade. Nanocarriers improve 
drug performance and have the ability to control and reduce drug release, as well as protect drug 
molecules and reduce their side effects by altering pharmacokinetic characteristics. Because of the small 
size of nanocarriers from the cell, they can pass through biological barriers or cell membranes and 
deliver drug to target point and improve therapeutic effect [7]. In making these nanoparticles, various 
materials such as polymers, nanotubes, metal particles, lipids are produced and used according to the 
methods and shape and size of the nano particles. DDS nanocarriers have now entered the global drug 
market and their use is increasing day by day. 
One of the diseases that humanity has faced is cancer, which is known with uncontrolled growth and 
spread of abnormal cells that causes patients to suffer. The causative agent can depend on various factors 
such as environmental and behavioral factors, hereditary radiation exposure, industrial pollution and 
smoke and alcohol consumption and etc. that predispose to the disease. Researchers are conducting 
extensive research to combat it and it is gaining global attention [8]. Carbon nanotube (CNT) is a unique 
nano material that can be useful in DDS. Since CNT was first introduced by Lijima [9] in 1991, scientists 
and researchers have found wide applications for them in various industries  such as gas detection 
sensors, hydrogen storage, solar cells, composite materials, semiconductors, etc [10–13]. CNTs are 
among the most promissing materials with a wide variety of capabilities and unique structural properties, 
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which make them one of the most commonly used materials in nanomedicine and pharmaceutical 
industries Among different nanomaterials, CNTs are considered as a novel alternative and efficient tool 
for the transportation and translocation of drug molecules. To enhance their solubility, the surface of 
CNTs can be functionalized with hydrophilic atoms [14]; therefore, before functionalization, selecting 
a nanotube with the most suitable structural and mechanical properties for the adsorption of drug 
molecules is of great importance. CNTs are among the most efficient materials with different capabilities 
and unique structural properties. 
1. 2. Literature review 
1. 2. 1. Drug Delivery Systems Based on Nano-Materials for Cancer Treatment 
Cancer is still among the most challenging health issues. With the spread of knowledge about this 
disease, many advances have been made to treat it. However, the toxic effects of chemotherapy drugs 
remain a problem because they often work non-specifically. Technically, cancer is defined as 
uncontrolled cell growth due to a vicious cell cycle. Previous studies have shown that certain behavioral 
and environmental factors, such as smoking, industrial pollutants, and radiation exposure  can make 
individuals vulnerable to cancer [8]. In the last two decades, new DDSs have been developed that have 
partially solved the problems associated with chemotherapy. These systems include nanoparticles 
containing organic and inorganic compounds. Some of these systems are now making their way into the 
pharmaceutical market, and many others are in the preclinical stages. Many new nanoparticles have also 
solved the problem of cellular resistance to the drug and provided a new arena in the treatment of cancer 
[15,16]. 
Currently, the limiting factor in cancer chemotherapy is the lack of selectivity of drugs against cancer 
cells. In addition, most anticancer drugs have a small therapeutic index, which causes toxic side effects. 
During chemotherapy, some cells become resistant to treatment, which either increases the dose of the 
drug during treatment or uses several drugs at the same time. But with these measures, the toxicity of 
the drug also increases. To reduce these side effects and improve existing drugs, various DDSs have 
been developed that include liposomes, polymer micelles, soluble drug-polymer conjugates, 
nanoparticles, and microparticles [17]. Among these, nanoparticles have received more attention 
because they have an easier production method and can be prepared through biocompatible polymers. 
Due to the fact that the vessels around the tumor tissue are more permeable than the vessels of normal 
tissues and also need more oxygen and nutrients due to their higher growth rate, as a result, they have 
better drug adsorption, which increases permeability, retention and persistence [11]. 
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1. 2. 2. Alcohol Consumption and Cancer 
Alcohol consumption, especially excessive consumption, is among the most critical risk factors for 
health and the development of various cancers such as cardiovascular disease, liver and pancreas disease, 
and etc, as well as other diseases such as diabetes, infectious diseases, neuropsychiatric disease, and 
intentional and intentional injury. According to the latest risk comparative studies performed by World 
Health Organization in 2009, the key effect of alcohol consumption on the global burden of disease and 
injury (it is one of the types of old risk factors such as contaminated water consumption, high cholesterol, 
unsafe sex in childhood and tobacco use have occurred [19]. When alcohol enters the body, it spreads 
through the blood vessels in the body and passes through blood-brain barrier to reach brain in just 5 
minutes, and its effects appear within 10 minutes [20]. Many research works have been performed on 
the determination of the intracellular impacts of ethanol in the body, but the extracellular effects have 
not yet been fully elucidated, especially in DDS [21]. 
Consequently, in this theoretical investigation, because of the significance of the extracellular impacts 
of ethanol, the mechanism of the penetration of encapsulated DOX-Single-walled carbon nanotube 
(SWCNT) through the membrane of cell in ethanol-containing solution will be explored by SMD 
simulations in chapter 4. With the advent of nanotechnology and its introduction to other sciences and 
its impact on other sciences, different types of nanoparticles with different structures and ingredients 
have been introduced that each have their own strengths and weaknesses and have been an effective step 
in Improve the performance of the particles. Among the most commonly applied nanoparticles for 
nanoparticles is drug delivery which has been achieved through various systems such as polymeric, 
lipid, metallic, ceramic carriers, and so on. They have severe diseases such as cancer. 
1 .2. 3. Segmentation of pharmaceutical nanocarriers 
In general, pharmaceutical carriers are classified into two major groups of inorganic and organic carriers. 
Each group can be subdivided into smaller subgroups as shown in Fig 1-1. 
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Fig. 1-1. Segmentation of pharmaceutical nanocarriers 
1. 2. 3. 1. Inorganic nanocarriers 
I. Ceramic nanoparticles 
Ceramic nanoparticles are often made of inorganic materials such as alumina and silica. Although, these 
particles are not limited to these two materials, and other metal oxides such as silver oxide or iron oxide 
and metal sulfides are also used in their fabrication in various dimensions and shapes. Also, these 
particles can be porous and create chambers to prevent damage by loading substances such as drugs 
inside themselves. By constructing these particles in different sizes and shapes, structures can be 
obtained to escape the reticuloendothelial system and to assist in drug delivery. The most widely used 
of these compounds are in drug delivery, silica and porous silica, with a well-known commercial 
prototype known as MCM-41. Due to the easy synthesis and the possibility of many surface 
modifications on these particles, ceramic materials are attractive carriers for drug delivery [22]. 
II. Metal nanoparticles 
These particles have been extesively applied in DDSs, disease detection and biosensor manufacturing. 
Various metal particles have been prepared and investigated; however, silver and gold are the most 
popular ones. These particles could be made in various shapes and sizes with narrow particle size 
distributions. A unique feature of these particles is their variable optical behaviors with particle size, i.e. 
nanoparticles with various sizes present various colors at visible wavelengths (Fig 1-2). This feature 
could be applied to diagnose diseases and medications and make it easier to diagnose and distribute 
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drugs. Surface modification of these particles is very easy and different ligands such as DNA, proteins, 
peptides sugars, and could be attached to these particles [23]. 
 
Fig 1-2. The colors of visible wavelength and microscopic structure of metal particle [24] 
III. Magnetic nanoparticles 
Superparamagnetic iron oxide nanoparticles are another critical and extensively applied class of 
inorganic substances in DDSs that can be fabricated using chemical methods such as biosorption or 
bacterial-assisted methods. Simple modification of particle surface as well as direct binding of ligands 
to particles are important advantages of these structures. Also, superparamagnetic properties allows 
these compounds to be applied in targeted drug delivery using magnetic fields. Drug-loaded magnetic 
nanoparticles could be directed to a certain point of body by applying an external magnetic field to bring 
drug molecules to a specific location in the body. The magnesite superparamagnetic (γ-𝐹𝑒2𝑂3) and 
magnetite (𝐹𝑒3𝑂4) nanoparticles are the main magnetic nanoparticles applied in DDSs. Generally, these 
particles are functionalized to enhance biocompatibility with polymers such as chitosan or dextran [25–
27]. 
IV. Carbon nanoparticles 
Over the last half century, various nanocarriers have been introduced due to great progress in different 
sciences such as chemistry, polymer, biology and physical and mechanical sciences. Asmatulu et al. 
[25] used magnetic nanocomposite particles to deliver drugs. In addition, these materials have been used 
in numerous industries such as gas detection sensors, hydrogen storage, solar cells, composite materials, 
semiconductors, etc. CNTs are the most powerful materials developed so far in terms of elastic 
modulus and  tensile strength   [28].Two of the compounds which have recently become very popular 
in medicine are fullerenes (also known as Bucky ball) and carbon nanotubes. Their shape, size, and 
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surface properties have made these particles usable in DDSs. The diameter of C60 fullerenes and single-
walled carbon nanotubes (SWCNT) (Fig. 1-3) is about 1 nm which is half the diameter of a DNA helix. 
Due to their tiny sizes, these particles can easily cross biological barriers and membranes and enter cells. 
These structures with high surface area make it easy to engineer the surface. Particle surfaces are 
functionalized with different groups and compounds to increase the biocompatibility, solubility and 
conductivity of various materials. These particles can be used as carriers for carrying biological 
molecules such as protein, DNA and drug. Medicinal substances can be loaded inside or onto these 
structures. Simultaneous targeting and transferring of two or more compounds are are also possible by 
these structures [29,30]. 
 
Fig. 1-3. Structure of a fullerene C60 (left) and a single-walled carbon nanotube transmission system (right) 
[24] 
1. 2. 3. 2. Organic Nanocarriers 
I. Liposomes 
Alec D. Bangham first identified liposomes in 1961. These bilayer vesicles are composed of a meiotic 
portion enclosed in a bilayer lipid membrane, which can be synthetic or natural phospholipids. The 
biocompatibility, amphiphilicity and simple surface modification are among the advantages of these 
compounds which make them a viable option for drug delivery. Doxil®, a pegylated liposome 
containing doxorubicin, was the first liposomal formulation introduced to pharmaceutical market (Fig 
1-4). The polyethylene glycol (PEG) present on the surface of these liposomes increases the half-life of 
doxorubicin circulation [31–33]. 
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Fig. 1-4. Doxil® formulation shows less cardiac toxicity, nausea, and side effects than doxorubicin 
formulations (Janssen Biotech, Inc) 
II. Solid Lipid Nanoparticles 
Solid lipid nanoparticles (SLNs) are another example of lipid nanoparticles which are composed of a 
solid lipid matrix of triglycerides, lipids, fatty acids, steroids whose sizes are less than 1 𝜇𝑚. Surfactants 
should be used in the formulations of these particles to enhance their stability. These nanoparticles could 
be applied in loading and transporting drugs with very low solubilities in aqueous media and release 
them to the desired position for a specified period of time, using various methods such as oral, injectable, 
and etc [34]. 
III. Polymeric nanoparticles 
Polymers are the most commonly used materials in delivering drug nanoparticles. The polymer 
employed for controlled drug release has to be non-toxic, biocompatible and free of leakable impurities. 
Physically, it should be well structured and have a half-life of what it desires. Natural or synthetic 
polymers coupld be applied in the preparation of polymer nanoparticles. Generally, polymeric 
nanoparticles are adoptd from biodegradable compounds. The advantage of using polymer nanoparticles 
is their high durability as well as the possibility of their mass production. Polymeric nanoparticles 
comprise a gret number of compounds including vesicular (nanocapsule) and matrix (nanosphere) 
systems. In nanocapsules, drugs are trapped inside polymer cavity but in nanospheres, they are dispersed 
in polymer matrix [35] . Abraxane® is the first polymer nanoparticle introduced by the company in 2005 
American Pharmaceutical Partners and American Bioscience have been introduced to the world 
pharmaceutical market, containing nanoparticles of paclitaxel that are bound to albumin. This 
formulation is free of a compound called chromophore-EL that was used in previous formulations of 
9 |P a g e  
 
paclitaxel to increase solubility. Chromophores cause severe allergies in some patients, sometimes life 
threatening. It has been successfully demonstrated that nanotechnology can introduce products that 
overcome formulation science problems [36] . 
IV. Polymeric micelles 
Polymeric micelles are self-assemblies consisting of block copolymers attached through non-covalent 
bonding. Block micelles have core-shell structures. The specific characteristics of micelles such as 
shape, size, aggregation number and critical micellization concentration (CMC) of final structure are 
directly dependent on the length and structure of polymer chains in copolymer block. Generally, 
polymeric micelles have low CMCs, which affect their ability to solubilize the loaded drugs and increase 
micelle stability. Micelles have been widely used in drug delivery due to their high capacity and variable 
drug loading, stability in physiological conditions, lower dissolution rate, greater drug accumulation at 
action site and the ability of surface modifications. The polymeric micelles NK911 contain doxorubicin 
and NK105 contain paclitaxel in the final stages of clinical trials to enter the world pharmaceutical 
market [37,38] . 
V. Polyethylene glycol polymer (PEG) 
Polyethylene glycol polymer (PEG) plays an important role in DDS. In these systems, it is commonly 
used to coat nanoparticles, drugs, and drug carriers to protect it. These types of polymers are very 
biocompatibility and dispersibility PEGs are non-toxic, colorless, inert, odorless, and non-volatile and 
fabricated by polymerizing ethylene oxide and the chemical structure and monomeric unit of PEG are 
H−(O−CH2−CH2)n−OH. Are known. Each monomer of PEG has a positive polar oxygen atom and a 
non-polar group (O−CH2−CH2)n. the main ingredient in antifreeze, using a ring-opening technique. This 
chain-like property makes it possible to make them with different molecular weights that are suitable 
for different uses [39]. Its structural shape is as follows Fig 1-5: 
 
Fig. 1-5. Chemical structure of polyethylene glycol polymer (PEG) monomer 
These polymers are soluble in polar and non-polar solutions such as water, dichloromethane, benzene, 
acetonitrile and ethanol while insoluble in hexane and diethyl ether. Also, widely employed as carrier 
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for hydrophobic drugs to improve their solubility and dissolution characteristics. PEGs are similar to 
COMP-LIKE in various structures such as branched, stellar and large molecules. PEGs are usually 
referred to as polymers with molecular weights of below 20,000 g/mol. PEOs are polymers with 
molecular weights of above 20,000 g/mol. POEs are also called polymers with any molecular mass. 
Polyethylene glycols have molecular masses in the range of 300 to 10,000,000 g/mol. Polyethylene 
glycols with a molecular weight of less than 1000 g/mol are liquid, but those with a higher molecular 
weight are solid powders [40]. PEGs can bind to other molecules by PEGylation [41,42], so it is one of 
the most effective agents for improving the surface area of a nanotube by non-covalent bonding to it, 
which takes the surface by wrapping. They can also prevent the adsorption of certain proteins by 
changing their coronal shape, which is one of the most promising methods in the medical industry and 
DDS [43]. 
VI. Chitosan polymer (CT) 
The use of polymers such as chitosan to deliver drugs to suitable sites in biological systems is of great 
interest. Chitosan is degraded in biological systems over time. Chitosan is a cationic polymer containing 
two hydroxyl groups and one amino group in its structure that can establish strong electrostatic 
interactions with CNTs and negatively charged biomolecules [44]. Its structural form is shown in the 
figure below. 
  
Fig. 1-6. Chemical structure of Chitosan (CT) monomer 
The degree of chitosan degradability can be controlled by controlling the amount of deacetylation. This 
feature makes controlled drug release possible in the body and thus increases their effectiveness. Free 
amine groups that positively charge chitosan are essential for drug delivery. These positive charges 
interact with the negative charges of bioactive drugs, polymers, and molecules. Because of its unique 
properties, chitosan nanoparticles have been employed in delivering a variety of drug molecules such as 
anti-hormonal drugs, insulin and anti-cancer drugs. Chitosan is a substance that can functionalize the 
surface of CNTs and due to its high solubility in solution, biocompatibility, and biodegradability and 
non-toxicity, it has a high combined ability. Therefore, chitosan is extensively employed in 
pharmaceutical and biomedical applications such as cancer treatment, biosensors and drug delivery have 
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been researched [45,46]. Chitosan-functionalized CNTs are also used to remove heavy metals from 
aqueous solutions, tissue engineering [47,48]. 
VII. Dendrimers 
Dendrimers are synthetic and branching macromolecules with tree-like structures with definite sizes and 
shapes. These structures are monodispersed and can be easily modified by chemical reactions or physical 
interactions, and drug molecules can either be complexed or encapsulated within the structure, with 
dendrimer. Dendrimers in drug delivery are often made of the following polymers: polyamidoamine, 
poly (glutamic acid), polyethyleneimine polypropyleneimine and polyethyleneglycol. In the 1970s, 
Vogel and Tomalia were the first people to synthesize dendrimers and achieve tree structures by putting 
monomers together. Structure of dendrimer and PAPAM dendrimer has shown in Fig 1-7 Vivagel® is 





Fig. 1-7. Structures of (a) dendrimer [51] and (b) PAPAM dendrimer ethylenediamine core 
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Fig. 1-8. The Vivagel® product that is used as a topical antivirus to prevent the transmission of AIDS and 
herpes virus. Due to the dendrimer structure, this product prevents the virus from attaching to the host body 
(Starpharma, Inc) 
VIII. Polymersomes 
Polymers are also composed of double-bonded copolymers, which are water-based bilayer structures 
and, if triple-block copolymer, three-layer structures. These structures have less penetration into the cell 
than liposomes (which also have phospholipid-like vesicles). The higher the hydrophobic part of the 
copolymer, the greater this property is. This advantage results in slower release of drug. Also, these 
structures have greater biological and mechanical stabilities than liposomes due to less vesicle and 
macrophage interactions in these structures, thus providing more drug protection. Despite all the benefits 
mentioned above, currently no such formulation exists in pharmaceutical markets [52] . 
IX. Hydrogel Nanoparticles 
Hydrogel nanoparticles are 3D polymeric structures mployed for drug encapsulation and transferring. 
These structures swell in water or environment and trap high volumes of fluids. There also exist 
stimulant-responsive hydrogels that cause environmental changes, such as changes in temperature and 
pH, to release the drug. These systems are also used for DNA and protein transfer, wound healing, 
biosensor fabrication and tissue engineering [53] . 
1. 2. 4. Drug delivery types of nanocarriers 
So far, we have introduced pharmaceutical carriers. All the efforts made in the manufacture of different 
carriers are to ensure that the drug is targeted and specific to its location. Here's a brief description of 
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how nanoparticles are delivered. Nanoparticles generally deliver drugs in both active targeting and 
passive targeting. In the passive mode, the systems reach the target location with the help of physico-
anatomical conditions. Nanoparticles smaller than 100 nm simply pass through reticuloendothelial 
system capillaries and reach spleen and liver macrophages and are swallowed by them. Knowing this 
feature can be used to treat liver and spleen diseases, in the sense that the drug first enters the 
macrophage and exerts its effectiveness by accumulating within it and then these macrophages as their 
defense system, they are used to treat liver and spleen diseases [54,55]. 
Another example of these conditions is the vascular permeability associated with a defective lymphatic 
and vascular system in cancerous tumors. This means that the drugs are less likely to be eliminated from 
circulation after leaving circulatory system and entering tumor-infected areas, thereby accumulating and 
thereby prolonging their therapeutic effect. Liposomes and polymeric and micellar particles make good 
use of this method for drug delivery. In addition, the environmental conditions of cancerous tissues also 
change. In cancerous tissue, often the temperature is slightly higher than surrounding tissue (usually 
above 40 degrees) and slightly lower pH (about 5.4) [56]. This feature can also be used to increase the 
efficiency of pH- and temperature-sensitive inactivation. In the active drug delivery method, it is 
possible to transfer drugs more specifically to the tissue and cells than the inactive drug. By targeting 
carriers with targeting compounds (targeting ligands) such as antibodies, this can be achieved. These 
changes are applicable to most nano carriers, which have been extensively studied in recent years [24]. 
1 .2. 5. Studied System Components 
1. 2. 5. 1. Single walled carbon nanotube (SWCNT’s) 
Carbon nanotubes are among the most critical and extensively applied materials which have become 
popular among scientists, especially in DDSs due to the unique characteristics of carbon nanotubes such 
as stability, strength, reservoir shape that can be stored spontaneously and protected. Because of their 
high hydrophobic surface areas, nanotube carbon atoms can form strong π-π Van der Waals and 
electrostatic (EL) interactions with aromatic rings of doxorubicin molecules [57]. The surface of CNTs 
could be functionalized with hydrophilic atoms to enhance their solubility [14]. Amine and carboxyl 
functionalized CNTs can act as pH sensitive drug carriers [58]; therefore, before functionalization, it is 
is of great significance to select a nanotube with the most suitable structural and mechanical properties 
for the adsorption of drug molecules. CNTs are among the most useful materials with different 
capabilities and unique structural properties, which make them one of the most commonly used materials 
in nanomedicine and pharmaceutical industries. Among their applications (such as storage and drug 
delivery systems) the side effects and toxicity of drugs could be decreased because of their ultra-small 
sizes and the way in which the drug is stored [29,59,60]. Because of their high surface areas, they could 
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be functionalized with different organic and inorganic atoms, which is advantageous in making them 
smart to release a precise amount of drug in certain target sites [61]. They can also be used as diagnosing 
devices, or biosensors, in nanomedicine [62,63]. Drug molecule carrying is one of these applications. 
Among its capabilities is the ability to cross biological barriers such as cell membranes to deliver drug 
molecules to a certain target site through an endocytosis mechanism [64–66], to increase drug viability, 
and  biocompatibility. It can thus be considered as a highly effective drug delivery system that enhances 
drug therapeutic efficacy [67]. It has drug molecules and prevents its degradation. Various methods have 
been developed to produce carbon nanotubes, such as chemical vapor deposition (CVD), laser ablation, 
and arc discharge [68], as well as its extensive surface area that allows it to be precisely engineered and 
functionalized both covalent and non-covalent methods to be applied in biomedical applications. Their 
small size and needle-shaped shape allow them to easily cross cell membranes through endocytosis 
without damaging the cell membrane. These properties make nanotubes more attractive and dynamic 
than other nanomaterials for use in transporting biomolecules and drugs. In addition, carbon nanotubes 
have inherent properties that make tracking and chemotherapy easier. Because of these salient properties 
of carbon structures, much research has been done on DDS to use them in the last two decades. In 
addition to being a drug carrier, carbon nanotubes can also act as sensors. For this reason, they have the 
ability of identification and elimination of cancer cells in the body [69] . 
1. 2. 5. 2. Functionalized carbon nanotubes (ƒ-SWCNT) 
It should be noted that pure carbon nanotubes are highly hydrophobic, and their biggest drawback in 
biological and pharmaceutical chemistry is their poor solubility and lack of dispersion, which can cause 
them to accumulate by van der Waals interactions in aqueous media [70]. This accumulation is not 
desirable in the DDS, because it increases its size and as a result is unsuitable for piercing the cell 
membrane and increases its toxicity and also reduces the rate of spread in the blood. Many studies have 
been done to solve these problems [71–73], these studies to improve their performance and reduce their 
toxicity, functionalization and biomolecular doping have suggested one of the useful methods to 
overcome their problems. Carbon nanotubes can have covalent π-π and non-covalent interactions with 
molecules by their outer surface and inside the cavity. Functionalizing the surface of the nanotube with 
hydrophilic atoms can solve the problem of aggregation. It can also control drug release, improve 
bioavailability, performance and sensitivity, and reduce pharmacological toxicity and carrier 
biocompatibility. That is why functionalization is widely used for the development of carbon-based 
nanocarriers. To address the lack of interaction among CNT, organic particles and polymer matrix [74], 
CNT surface is functionalized with carboxylic group through treatment with sulfuric acid (H2SO4) and 
nitric acid (HNO3) [75]. The functionalization of CNT surface with hydroxyl group is achieved by 
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hydrothermal treatment. Amide group is also formed by the reaction of carboxylated CNT with sodium 
dodecyl (SOCL2) [76]. 
Another effective method is the functionalization of nanotube surface with non-organic metal oxide 
particles such as TiO2, Al2O3 Fe3O4, SiO2 [77–80]. TiO2 particles have been used to functionalize the 
surface of polymer membranes due to their high hydrophilicity and excellent chemical stability [81]. 
Addition of TiO2 onto acid treated CNT surface is done by photocatalytic reaction. CNT is one of the 
excellent materials for photocatalytic reactions [82]. During the photocatalytic reaction, an electron is 
transferred from TiO2 to CNT surface by decreasing electron hole pairs [83]. This decrease of electrons 
increases the hydrophilicity of nanotube surface in organic and polymeric environments. Also, adding 
Fe3O4 particles on nanotube surface, along with improving its hydrophilicity, enhances electrochemical, 
magnetic and antifouling properties and adsorption of some specific organic molecules [78]. Atomic 
layer deposition is another method for coating the surface of materials such as CNT and graphene. 
Recently, many studies have been performed on coating using ALD method for functionalization instead 
of acid treatment [84–86]. 
Carbon nanotubes are promising DDS carriers for prolonging drug release and drug accumulation at 
tumor sites by improving penetration. The bonding strength of drug molecules to carbon nanotubes as 
well as the amount of its release can vary in different pH environments [87]. The aim of this research 
was to explore solution effect and introduce hydroxyl and carboxylic functional groups and 
biocompatible polymers of chitosan and polyethylene glycol for drug molecule adsorption onto 
nanotube. For this reason, knowing the structural properties, bond energies, electron charge transfer, 
chemical reactions in the drug-nanotube set is for further studies on the carbon nanotube carriers of 
DDS. Fig 1-9 shows the different methods for functionalization of SWCNT: 
 
Fig. 1-9. Different methods for functionalization of CNTs [88] 
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1. 2. 5. 3. Doxorubicin Drug Molecule (DOX) 
Doxorubicin is one of the chemotherapy drugs and a compound of anthracycline cytostatic antibiotic 
with molecular formula C27H29NO11. It is employed to treat many cancer types, including breast, 
stomach, thyroid, bladder, bone, lung, muscle, nerve, joint and soft tissue cancers. It can also be used 
for Hodgkin's disease and various types of leukemia. It intercalates between base pairs in the helical 
structure of DNA and prevents its replication of the synthesis of protein. It also stops or slows cancer 
cell growth by blocking the activity of topoisomerase enzyme II, which is crucial for cell division and 
growth. Doxorubicin is a toxic compound that can damage healthy cells, in addition to cancer cells, in 
the bloodstream [89]. Therefore, nano-carriers play a key role in improving the application of 
chemotherapy drugs  and reducing damages on non-cancerous cells. Fig 1-10 shows the chemical 
structure of doxorubicin. 
 
Fig. 1-10. Doxorubicin structure and size (oxygen red, carbon grey, hydrogen white, nitrogen blue) 
1. 2. 5. 4. Cell membrane 
The body of living things is made up of billions of cells, and each of these cells is surrounded by a cell 
membrane. The cell is the basic body unit, and all the cells of the organs of the body have a membrane 
that separates the cell from its surroundings as a barrier. This outer cell layer is also called plasma. The 
membrane is made up of two layers of lipids and proteins that surround the cell, separating the inner 
contents of the cell. This membrane is permeable, meaning that it allows only specific molecules to enter 
and exit, and also controls the amount of molecules entering and leaving (cytoplasm) [90]. Water 
molecules can pass freely through very small amounts. Large molecules such as carbohydrates and 
amino acids and high-charge molecules such as ions cannot enter cell membrane directly. Scientists use 
the fluid mosaic model to define cell membranes [91]. This means that cell membrane is not solid and 
is flexible. Cell membranes have fluid stability because they are made of many phospholipids, and 
because of this feature, proteins can pass through them easily. The term mosaic is used because the 
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plasma membrane contains a variety of proteins and phospholipids, cholesterol molecules, and 
carbohydrates in its structure. 
Phospholipids are the main constituents of cell membranes and are a group of lipids and are acomposed 
of a head of phosphate group and a tail of two fatty acids. This property allows them to spontaneously 
form a bilayer membrane. Phospholipids when are in aqueous solution or in the body, the hydrophilic 
heads of the water rotate and position themselves close to the water and the outer layer, while the 
hydrophobic tails are adsorbed in and out of the water environment. This process results in the formation 
of bilayer phospholipids. It is noteworthy that aqueous fluids are found outside the extracellular fluid 
cell and inside an intracellular fluid cell [92]. The molecular view of the cell membrane has shown in 
Fig 1-11 . 
 
Fig. 1-11. Molecular view of the cell membrane (Encyclopaedia Britannica, Inc) 
Cholesterol is among the most important cell membrane components. The cholesterol molecule is 
composed of four rings of carbon and hydrogen atoms which are hydrophobic and exist in the 
hydrophobic tail of lipid bilayer. Cholesterol molecules play a key role in maintaining the stability of 
cell membranes and controlling the entry and exit of neither too many nor too few molecules. As 
cholesterol levels decrease, the membrane becomes more fluid and more permeable to the entry of 
molecules. In other words, cholesterol strengthens the entry of small molecules. These molecules also 
block the contact of phospholipid tails and solidification, in other word it makes membrane becomes 
flexible and fluid [93,94]. Some membrane proteins inside lipid are bilayer called integral proteins. 
Some are outside lipid bilayer, called peripheral proteins, although this type is also rarely found inside 
the membrane. Membrane proteins can accelerate chemical reactions as catalysts, act as enzymes, and 
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play the role of receptors for specific molecules or transport them into cell membranes. Sugars or 
carbohydrates sometimes bind to lipids or proteins found only on the outer layer of cell membrane. Their 
set is called glycocalyx. Glycocalyces have many uses, they act as protectors of cell membranes, as well 
as holding cells together. Another important function is that depending on the type and structure of 
carbohydrates in glycocalyx, body can identify cells and determine if they should be here [95]. 
1 .2. 6. Atomic Layer Deposition (ALD) and application in biomedical Science 
Atomic layer deposition is a technical and chemical process for the deposition of thin films in layers and 
sequentially using gas reactants. This technique is a subclass of chemical vapor deposition (CVD). Most 
use two gas reactors in ALD, also called precursors. These precursors react sequentially with the 
material surface and in a self-limiting manner. By continuing and repeating these depositions, a uniform 
thin film is slowly formed on the material. ALD is widely used for the production of semiconductor 
devices, the fabrication of nanomaterials, as well as the modification of nanoparticles and atomic doping 
[96–98]. In this method, precursors are never presented in the reactor simultaneously and the surface of 
the material is exposed to two precursors A and B in succession without overlapping and self-limited 
manner, unlike the CVD method where the accumulation of layers is steady-state is done. Reactive 
molecules can also react with a limited amount of sites of substrate. After the entire surface of the 
material in the reactor has accumulated one layer, the growth of the layer stops and the rest of the 
precursors are flashed and purging by Argon (Ar) and nitrogen (𝑁2) gases to prepare the reactor site for 
the arrival of second precursor. As this reaction changes successively, a thin layer deposited on top of 
each other [99,100]. ALD used to improve CNTs solubility, decrease their toxicity and make them smart 
for releasing in target sites [101]. 
In terms of process time, the ALD process can be divided into two times: first, when the material surface 
is exposed to precursor, and second, purge time, when it takes time to discharge the remaining chamber 
gases to enter second precursor. The time it takes to complete a step in this process is called an ALD 
cycle. However, the growth rate is used to define the amount of film growth per cycle. The Fig 1-12 
shows a cycle of aluminum oxide atomic layer deposition onto a hydroxyl surface and purging by water 
vapor [102]. 
Being able to produce antibacterial materials and specify the characteristics of the surfaces of biomedical 
devices, especially devices that are implanted in the body, is of great importance. Material surfaces 
interact with the environment, so surface characteristics play important roles in biological protein 
uptake, cellular interactions, and immune responses. Applications of ALD in biomedical, construction 
of sensors for medical diagnostic instruments, modifying nano porous membranes and drug delivery, 
which can be used to narrow the cavities of nano porous materials evenly, reduce the size of this cavity 
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which useful for specific applications. modifying polymers, making biocompatible implants with 
titanium (Ti) coated surface, tissue engineering, making accurate flexible sensors, for example in 
athletes’ clothes to measure heart rate and etc [84]. Tommi et al. [103] used ALD to coat the surface of 
solid acetaminophen particles with TiO2 and ZnO molecules and thereby improve the efficiency of the 
drug. Among the most challenging advantages in cancer treatment, ALD is receiving increasing global 
attention in both research and medical practice. 
The ALD technique is mainly performed in two ways: Thermal ALD and Plasma ALD. In Thermal 
ALD, the process requires a high temperature of about 150 to 350 C and occurs by surface reactions. In 
this method, the coating operation is performed without the importance of material geometry and the 
design of the reactor with precise and controlled thickness. In Plasma-ALD method, due to the high 
reactivity of plasma, it performs coating at a lower temperature without affecting the quality of the film. 
Also, in this method, various precursors and substrates can be used. One of the applications of Plasma-
ALD is to deposit organic molecules whose structure is sensitive to high temperature. This process is 
also performed by combining Molecular layer deposition (MLD) [104] . 
The MLD technique can be considered the sister of the ALD technique, this technique is used when we 
want to use organic precursors. Using a combination of MLD and ALD, superstructures and 
nanolaminates, thin films of organic polymers such as polyimine, polyester, polyamide, polythiurea, 
polyurethane, polyurea, polyimide  amide, polyimide, and hybrid films containing a combination of Al, 
Zn metal atoms can be used. Mn, Fe, Si, V, Hf, Zr and Ti are made with very high uniformity [105]. 
 
Fig. 1-12. Schematic diagram of one aluminum oxide Al (𝐶𝐻3)3 atomic layer deposition (ALD) cycle [102] 
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1. 3. Dissertation objective 
In this work, we selected carbon nanotubes as anti-cancer drug doxorubicin carrier. In the first chapter, 
at the background, we introduced the historical aspect and main introduction of drug delivery systems 
and its generations. In the second chapter, we theory investigated the mechanism of the adsorption of 
anticancer drug doxorubicin on the surface of pristine and functionalized single-walled carbon nanotube 
as a drug delivery vehicle, and the bonded and thermodynamic energies were exchanged, and the 
electron exchange was investigated using DFT quantum theory. The methods and effect of 
functionalization on these properties are also described. In the third chapter, we performed molecular 
dynamic simulation to comprehend the effect of mechanical properties of nanotubes on the process of 
drug adsorption and encapsulation by performing molecular dynamics simulations. Finally, In the fourth 
chapter, we performed SMD simulation for predicting the effect of alcohol consumption or presence of 
ethanol molecule on extracellular environment in endocytosis process (cellular uptake). With comparing 
the results, we found that the presence of ethanol on extracellular ambient reduces the penetration 



















Theorical investigation of adsorption mechanism of Doxorubicin 
anticancer drug on the Pristine and functionalized single-walled carbon 
nanotube surface as a drug delivery vehicle: A DFT Study 
 
2. 1. Introduction 
In the recent decade, extensive attention has been paid to carbon nanotubes (CNTs) and its 
applications on different industries due to their superior mechanical properties such as tensile and stress 
strengths and elasticity [28,106], as well as unique chemical and thermal properties [107]. Due to their 
intrinsic properties and high dynamism, they have been recently applied as drug adsorbers in medical 
and pharmaceutical industries [11,29,108] Furthermore, due to their characteristic surface properties and 
capsule and needle like shape, they can encapsulate a variety of biomolecules such as drugs and DNA 
molecules. They can also vertically pierce and penetrate cell membrane through endocytosis process 
[64] and, as carriers, protect their payloads against environmental hazards or prevent the unwanted 
distribution of anticancer drugs until reaching the target site in body tissues. It is noteworthy that, pristine 
CNTs are highly hydrophobic and their most important disadvantage in biological and pharmaceutical 
chemistry is their weak solubility and dispersibility, which can result in the accumulation of these 
compounds by Van der Waals interactions in aqueous environments. This accumulation is not favorable 
in drug delivery system (DDS) systems since it increases their size and therefore, decreases their ability 
to pierce cell membrane, resulting in the increase of their toxicity and decrease of their dispersibility in 
blood [71,109]. 
Many research works have been performed on the application of different carbon nanotube 
structures such as CNTs, fullerene, graphene sheets and graphene oxide in drug delivery systems 
[60,63,110]. CNTs, fullerene and graphene sheets have high surface areas which can be engineered. For 
example, they can be precisely fabricated and functionalized through different methods such as chemical 
vapor deposition (CVD), acid washing and atomic layer deposition (ALD) [69,86,111]. A great amount 
of research has been conducted to functionalize carbon atoms using different techniques to solve CNT 
defects and issues [14,72]. Among the most important applications of ALD in medical industry, is in 
the medical biosensors, drug delivery, and gas detection sensors [112] using very accurate layer by layer 
coating technique. Also, they are of great importance in today’s research areas to reinforce body 
implants and make them biocompatible to physiological conditions of the body by making them resistant 
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to erosion and oxidation. Recently, Zhu et al. [84] studied the functionalization of titanium implants 
reinforced with CNT and chitosan composite using ZnO particles deposited by using ALD method to 
improve its antibacterial properties. 
CNTs can create noncovalent and covalent π − π interactions with molecules via their outer and 
inner cavity surfaces [113]. Functionalization of CNT surface with hydrophilic atoms can solve 
accumulation problems. This can also improve drug release control, bioavailability, performance, 
sensitivity and biocompatibility of the carriers and decrease their pharmacological toxicity. Therefore, 
functionalization is widely being used to expand carbon-based nano-carriers. CNTs are promising DDS 
carriers to extend drug release duration and accumulate drugs at tumor site by improving their 
infiltration. The bonding strength of drug molecules with CNTs and the amount of drug release may be 
different at different pH values [114]. DOX is a chemotherapy drug and a anthracycline cytostatic 
antibiotic with molecular formula C27H29NO11. This drug is applied in the treatment of different types 
of cancers such as breast, stomach, thyroid, bladder, bone, lung, muscle, neural tissue, joint and soft 
tissue cancers. It is also applied for treating Hodgkin’s diseases and different types of blood cancer 
[115]. 
DOX is intercalated between base pairs in DNA helical structure and blocks DNA replication for 
protein synthesis. It also decelerates or blocks the growth of cancer cells through deactivating 
topoisomerase enzyme II, which is vital for the growth and division of cells. DOX is toxic and, along 
with cancer cells, can damage healthy cells in bloodstream [116]. Hence, nano-carriers can greatly 
improve the application of chemotherapy drugs and reduce their damage to non-cancerous cells. Due to 
the application of nanotechnology, new DDS systems can decrease the amount of the released drug and 
perform drug delivery function in a controlled manner; they protect drug molecules and due to their very 
small size, they can easily pass through biological barriers and deliver the drug at target point and also 
increase biocompatibility [117]. Due to their intrinsic properties, CNTs can act as suitable drug carriers 
to deliver toxic anticancer drug DOX to decrease its side effects [89]. Other nano-carriers of DOX, such 
as liposome, dendrimer, fullerene, metal oxide particles, biocompatible chitosan polymers and 
polyethylene glycol, have also been applied [118–120]. Different nanocomposite carriers have also been 
applied to deliver DOX molecules [45]. Due to their metallic and semi-conductive properties, carbon-
based nano-structures have high potential to be used as sensors in nano-scaled devices. They can be also 
applied in gas detection sensors and biosensors [121]. Due to their unique electronic properties, CNTs 
can react well with different gas and biomolecules. For example, attaching Pd atom onto CNT surface 
can improve the interaction of gas molecules with CNT surface and therefore the sensitivity of these 
sensors [122]. San et al. [123] applied suspended carbon nanotube (SWCNT) as biosensor for the 
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detection of DNA. Recently, Elizabeth et al. [124] performed DFT calculations for the adsorption and 
diffusion of atomic hydrogen on metal surfaces. 
The main aim of this Chapter was to investigate the ability of pristine and hydroxyl- and carboxyl-
functionalized CNTs in the adsorption of DOX and the effects of aqueous and gas phases on this process 
using DFT theory. In the initial combination of these systems, drug molecules at their most stable state 
were arranged at different locations on CNT surface such that they can spontaneously be adsorbed onto 
and interact with CNT surface via its active atom. Our goal in performing more detailed studies on these 
interactions was to investigate structural properties before and after adsorption and obtain the energies 
of bonding, adsorption and deformation in gas and aqueous phases. To more precisely understand the 
nature of bonds, quantum theory of atoms in molecules (QTAIM) and topological parameter calculations 
were performed. Electronic properties and corresponding descriptors were obtained in both phases and 
the differences of pristine and functionalized CNTs were analyzed. We also performed thermodynamic, 
enthalpic, PDOS and TDOS analyses on adsorption process and fragments. Finally, using the natural 
bond orbital (NBO) method, investigated the amount and direction of charge transfer from active orbitals 
of CNT and drug molecules. 
2. 2. Theoretical details 
Quantum mechanics calculations 
In the current work, the interaction of hydroxyl- and carboxyl-functionalized armchair (6, 6) 
SWCNT and DOX anticancer drug in aqueous and gas phases has been studied. The effect of water 
solvation on interaction nature was evaluated using self-consistent reaction field (SCRF) with Tomasi’s 
polarizable continuum model (PCM) [125,126]. All calculations were performed based on DFT method 
at WB97XD/6-31+G(d,p) special level. This level of theory is very popular for NT structures [127,128]. 
6-31+G basis set was suitable for general calculations of molecules with medium to huge sizes. (6, 6) 
pristine CNTs, which were applied in CNT functionalization, contained 132 carbon atoms with their 
open ends saturated with hydrogen atoms. All computations were performed using Gaussian 03 software 
package [129]. 
2. 3. Results and Discussion 
2. 3. 1. DFT Results 
2. 3. 1. 1. Analysis of Molecular Geometry  
To obtain the configuration with the highest stability, the interactions of DOX molecule with CNT 
and f-CNTs as drug carriers at various positions have been studied. Following structural optimization, 
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drug molecule re-arrangements in some configurations were predicted to find the most stable 
configuration. Figs. 2-1 and 2-2 show the optimized geometries of anticancer drug DOX, CNT, and f -




    
f-CNT1  P-CNT f-CNT2 
Fig. 2-1. The optimized geometries of DOX, Hydroxylated (f-CNT1), pristine CNT (PCNT) and Carboxylated 
(f-CNT2) 
 




























Fig. 2-2. Final optimized geometries of DOX/NTs complexes at the most stable state of energy, calculated by 
WB97XD/6-31+G (d, p) method (A: complex with pristine CNT; B, C and D: complexes with hydroxylated 
CNT; E, F and G: complexes with carboxylated CNT) 
The geometries of pristine, carboxylated and hydroxylated armchair (6,6) CNTs with diameter 8.5 
Ǻ, length 14 Ǻ and two saturated ends applied as nano vectors for the adsorption of DOX were totally 
optimized at the WB97XD/6-31+G (d, p) level of theory. Table 2-1 lists some critical bond angles and 
lengths. The lengths of optimized P-SWCNTs before and after adsorption were calculated to be 14.02 
Å and 11.57Å, respectively. However, the nanotube lengths in other complexes of ƒ-CNT were fixed at 
14 Å. Table 2-2 lists the structural parameters of DOX before and after being adsorbed onto the surface 
of nanotubes with selected configurations (i.e. A, B, E). Also, analyzing structural parameters at 6-31+G 
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(d, p) indicated that drug molecule bond lengths in the considered complexes remained almost constant 
with respect to WB97XD functional (Table 2-2). However, no significant perturbation was witnessed in 
the relaxed geometry of DOX molecules after being adsorbed onto the surface of nanotubes with the 
studied configurations. One could conclude that nanotubes acted as drug carriers and protected DOX 
molecules from degradation. 







Bond length (A ֯)  
Bond angle label 
Bond angle (degree) 
Before ads After ads Before ads After ads 
 
A 
C63-C74 1.346 1.476 C61-C63-C74 122.017 121.120 
C61-H104 1.070 1.070 C63-C61-H104 119.692 120.227 
 
B 
O158-H158 0.970 0.980 C124-O157-H158 109.737 114.928 





C169-O170 1.341 1.324 O170-C169-O171 123.114 124.641 
O170-H176 0.971 1.004 C169-O170-H176 113.026 117.084 
C169-O171 1.204 1.211    
C118-C169 1.533 1.531    
 









Bond angle (degree) 
Before 
ads 
After ads Before 
ads 
After ads 
CONF-A CONF-B CONF-E CONF-A CONF-B CONF-E 
N55-H56 1.007 1.008 1.007 1.008 H56-N55-H57 109.60 109.64 109.79 109.70 
N55-H57 1.008 1.008 1.008 1.008 C48-O47-C27 117.52 119.29 115.61 117.54 
O47-C48 1.422 1.421 1.436 1.438 C32-O33-H34 111.73 112.19 108.47 111.41 
O47-C27 1.448 1.446 1.458 1.464 C12-O38-H39 111.22 111.24 111.23 111.47 
C32-O33 1.439 1.435 1.433 1.436 H36-C35-H37 107.54 107.32 107.47 108.26 
O33-H34 0.968 0.967 0.973 0.967 C1-O17-C14 122.20 122.20 122.18 117.84 
O38-H39 0.977 0.977 0.977 0.976 C9-O25-H26 110.54 110.50 110.53 110.93 
C12-O38 1.356 1.356 1.357 1.355 H43-C42-H44 107.42 107.89 108.71 107.99 
C21-O22 1.232 1.232 1.232 1.235 C40-C42-O45 107.43 110.89 111.97 109.83 
C35-H36 1.085 1.081 1.083 1.083 C9-C7-C23 119.42 119.37 119.39 119.40 
C35-H37 1.081 1.082 1.079 1.080 C62-O64-C48 114.38 113.90 114.54 114.75 
C4-H20 1.068 1.068 1.068 1.068 O33-C32-C40 109.15 109.99 110.01 104.12 
C1-O17 1.350 1.350 1.351 1.372      
O17-C14 1.450 1.450 1.450 1.466      
C23-O24 1.231 1.231 1.231 1.232      
C9-O25 1.356 1.354 1.355 1.355      
O25-H26 0.979 0.979 0.980 0.979      
C40-O41 1.211 1.216 1.212 1.216      
O45-H46 0.966 0.967 0.966 0.970      
C5-C8 1.399 1.398 1.398 1.399      
 
29 |P a g e  
 
2. 3. 1. 2. Analysis of Binding Energy 
For the characterization of DOX-nanotubes interaction, adsorption energy (Eads) of the complexes 
were obtained using the following equation: 
Eads = ECNT/DOX − (ECNT + EDOX)                                                                                                                (1) 
where EDOX, E𝐶𝑁𝑇 and ECNT/DOX  are total electronic energies of isolated DOX drug, isolated CNT and 
optimized DOX/CNT complex, respectively. 
Boys-Bernardi counterpoise technique was employed to correct binding energies for basis set 
superposition error (BSSE) [130]. BSSE was determined using counterpoise (CP) method. Adsorption 
energy includes deformation (Edef) and interaction (Eint) energy contributions, both of which occur 
during adsorption. The following equations were employed for the calculation of these contributions: 
Eads = Eint + Edef                                                                                                                                            (2) 
Eint = ECNT/DOX − (ECNT in complex + EDOX in complex)                                                                                  (3) 
Edef = Edef CNT + Edef DOX                                                                                                                                (4) 
where ECNT/DOX is the total energy of optimized CNT/DOX complex and EDOX in complex and 
ECNT in complex are total energies of drug fragments and nanotubes in the final optimized geometry of 
CNT/DOX complexes, respectively. Also, Edef DOX and Edef CNT are the deformation energies of DOX 
and nanotube molecules in the complex, respectively. 
Tables 2-3 lists the deformation (𝐸𝑑𝑒𝑓) interaction (𝐸𝑖𝑛𝑡) and adsorption (𝐸𝑎𝑑𝑠) energies of the 
studied systems in aqueous and gaseous phases calculated through Eqs. (1) to (4). The calculated binding 
energy values for pristine SWCNT complex were -4.637 and -6.390 Kcal/mol and corresponding values 
for hydroxylated CNT complexes (i.e. B, C, and D) ranged from -13.796 to -17.829 Kcal/mol and -
18.859 to -33.022 Kcal/mol and for carboxylated CNT complexes from -33.508 to -39.978 Kcal/mol 
and -40.549 to -43.674 Kcal/mol in aqueous and gaseous phases, respectively. It was found that the 
binding energies of all appropriate structures in aqueous media were lower than the values obtained in 
gaseous phase. It was also found that, the calculated binding energies were negative in all cases, which 
indicated that adsorption process was exothermic and favorable in both phases in the majority of the 
evaluated systems (Tables 2-3). In addition, considering the results given in Tables 2-3, it was found 
that binding energies were mainly under the influences of the orientations and locations of DOX 
molecules. Also, our theoretical calculations revealed a good relationship between the 𝐸𝑖𝑛𝑡 and 𝐸𝑎𝑑𝑠  in 
adsorption structures. It was also concluded that increase of interaction energy shifted binding energies 
toward more negative values making intermolecular interactions stronger. Further, the contribution of 
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interaction energy in the evaluated configurations (Table 2-3) confirmed that DOX molecules were 
physiosorbed onto the surface of NTs. 
Following optimization, pristine CNT complex (A), (Fig. 2-2) presented negative binding energies 
-4.637 and -6.390 Kcal/mol in aqueous and gaseous phases, respectively. In the configuration with the 
highest stability, one Van der Walls (VdW) interaction between carbon atom C74, CNT surface and 
H176 atom of drug molecule was formed with distances of 3.319 and 3.673Å in PCM and gas phases, 
respectively. Also, a weak H bond was formed between H104 atom of CNT in terminal and O151 atom 
of DOX with intermolecular O…H distances of 2.339 and 2.342 Å in PCM and gas phases, respectively. 
These values proved the presence of VdW interactions between P-SWCNT and DOX drug molecules. 
They also indicated that the strengths of P-SWNTs-DOX interaction was very weak. To enhance binding 
strengths, the electronic and structural characteristics of SWCNT, -COOH and -OH functional groups 
were attached onto the exterior surfaces of nanotubes (ƒ-SWCNTs). 
After optimizing hydroxylated CNT (ƒ-CNT1) complexes (i.e. B, C, and D complexes), the 
intermolecular distance from DOX to ƒ-CNT1 surface was in 1.624-2.313Å range and configuration C 
was found to be the most stable structure (Fig 2-2) and therefore it had the most negative binding 
energies in aqueous and gaseous phases; i.e. -17.829 and -33.022 Kcal/mol, respectively. In this 
configuration, 3 hydrogen bonds were formed on nanotube surface. In aqueous phase, one hydrogen 
bond was created through the interaction of H166 atom of -OH group on the surface of CNT and O214 
atom of DOX molecule (DOX molecule was diagonal to CNT surface) with intermolecular O…H 
distance of 1.777 Å. The second hydrogen bond, which was common in both phases, was formed through 
the interaction of O159 atom of -OH group on CNT and H203 atom of DOX with intermolecular O…H 
distances of 1.654 and 1.783 Å in PCM and gaseous phases, respectively. Finally, the third hydrogen 
bond was formed in gas phase through the interaction of H158 atom of -OH group on CNT and N224 
nitrogen atom of DOX with intermolecular N…H distance of 1.826 Å, (DOX molecule was parallel to 
CNT surface). It should be kept in mind that the binding with the most negative energy, which was 
formed between hydroxylated f-CNT1 and DOX molecule in configuration C, was because of more 
intermolecular hydrogen bond (HB) interactions. Following configuration C, configuration D had the 
most stable state among hydroxylated CNT configurations with binding energy of -16.040 and -29.645 
Kcal/mol in aqueous and gaseous phases, respectively. At the most stable state, this system had two 
dominant hydrogen bonds. The first one was formed between O191 oxygen atom of carbonyl group on 
DOX molecule and H163 hydrogen atom from the hydroxyl functional group on CNT surface with bond 
distances of 1.823 and 1.903 Å in aqueous and gaseous phases, respectively. The second bond was 
formed between O159 oxygen atom of f-CNT1 and H203 hydrogen atom of DOX with intermolecular 
distances of 1.903 Å. 
31 |P a g e  
 
In configuration B, a hydrogen bond was formed between H158 hydrogen atom of hydroxyl group 
on the surface of CNT and O216 oxygen atom of DOX with bond distances of 1.825 and 1.798 Å in 
aqueous and gaseous phases, respectively. Weak VdW bonds were formed between H233 hydrogen 
atom of drug molecule and H199 hydrogen atom on CNT surface. In final optimization of the system, 
aromatic rings of DOX were arranged along CNT axis. After optimizing carboxylated CNT (ƒ-CNT2) 
complexes, the intermolecular distances of ƒ-CNT2 surface and DOX molecule were in 1.573-2.496 Å 
range with configuration F being the most stable structure (Fig 2-2) which had the most negative binding 
energies of -39.978 and -43.674 kcal/mol in aqueous and gaseous phases, respectively. In the 
configuration with the highest stability, two main hydrogen bonds were formed on CNT surface. The 
first hydrogen bond was formed through the interaction of H175 atom of -COOH group on CNT and 
O203 atom of DOX (DOX molecule was perpendicular to CNT surface) with intermolecular OH 
distances of 1.702 and 1.698 Å in aqueous and gaseous phases, respectively. However, the second one 
was formed between H176 atom of -COOH group of f-CNT2 and N234 nitrogen atom of DOX with 
N…H distances of 1.672 and 1.679 Å in PCM and gas phases, respectively. 
In the most stable state of configuration E, the arrangement of DOX molecule was similar to the 
configuration B, where O266 oxygen atom of DOX formed a dominant hydrogen bond with the 
hydrogen atom of carboxyl group on CNT with minimum intermolecular distance of 1.573 Å in aqueous 
phase in the studied system. In configuration G, DOX molecule was located 180ᵒ opposite to the position 
of DOX molecule in complex F which resulted in the formation of three hydrogen bonds, two of which 
were formed by -OH of drug molecule, i.e. O168…H218 and O224… H176 with bond distances of 
1.869 and 1.633 Å and 1.766 and 1.573 Å in aqueous and gaseous phases, respectively, and the other 
one was formed by O201 oxygen atom of carboxyl functional group of DOX molecule and H175 
hydrogen atom of carboxyle functional group on CNT surface with bond distance of 1.736 Å in both 
phases. Also, as given in Table 2-3, the deformation energies of the evaluated models were in 4.746–
18.210 Kcal/mol range. The obtained results revealed that, remarkable deformation occurred in the 
molecular geometry of DOX during the forming some of configurations. It is well established that by 
the increase of the strength of interaction increases the intensity of curvatures in carriers during 
conjunction with DOX molecule. The results given in Table 2-3 show that the strength of interaction 
between drug and ƒ-CNTs was higher than that with P-CNT. The maximum and minimum energies of 
deformation were found to be 18.21 and 4.746 Kcal/mol for systems E and A, respectively, which meant 
that the distortion in the geometry of drug and nanotube in the ƒ-CNT system’s is significantly higher 
than P-SWCNT system (Table 2-3). 
Adsorption energy magnitude at WB97XD level of theory for the above discussed complexes was: 
P-CNT<Hydroxylated CNT<Carboxylated CNT 
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Therefore, the obtained results revealed that the addition of -COOH and -OH functional groups onto 
the exterior surfaces of NTs markedly enhanced the stability of configurations and adsorption process. 
Based on our theoretical findings, configurations C and D showed weaker interaction between f-
CNT1 and DOX molecules in aqueous solutions than gas phase. More detailed investigation of the data 
presented in Table 2-3 showed that adsorption energies in complexes C and D were significantly 
different in aqueous and gas phases. The initial structure selected for the investigation of drug molecule 
adsorption on f-CNT revealed that DOX molecules were aligned parallel such that their aromatic rings 
were located on the surface of nanotubes in both phases. It was witnessed in the optimized structure of 
configuration C that three intermolecular hydrogen bonds were formed between the functional groups 
on nanotube surface and DOX molecules namely N224…H158 in gas phase, O214…H166 in aqueous 
phase, and O159…H203 in both phases. In configuration D, however, two intermolecular hydrogen 
bonds between the functional groups on nanotube surface and DOX molecules which included 
O159…H203 in gas phase and O191…H163 commonly in both PCM and gas phases. More detailed 
evaluation of the data presented in Tables 2-3 also revealed that intermolecular hydrogen bond (HB) 
interactions in aqueous phase were weaker than those occurring in gas phase. In gas phase, stronger 
intermolecular interactions were formed between f-CNT and DOX molecules. So, the adsorption energy 
of functionalized nanotubes and drug molecules was greatly improved in gas phase. 
Table 2-3. The calculated adsorption energy (Eads), interaction energy (Eint) and deformation energy (Edef) (all 
in Kcal/mol) in DOX/CNT and DOX/ƒ-CNT systems for all complexes 
MODEL Eint Eads Edef 
PCM GAS 
A -11.136 -4.637 -6.390 4.746 
B -31.851 -13.796 -18.859 12.992 
C -47.902 -17.829 -33.022 14.880 
D -46.126 -16.040 -29.645 16.481 
E -59.271 -33.508 -41.060 18.210 
F -59.664 -39.978 -43.674 15.990 
G -54.595 -37.470 -40.549 14.046 
2. 3. 1. 3. QTAIM Analysis 
To better understand the nature of interatomic interactions based on electron density distributions 
for detecting bond critical points (BCP) and calculating their values through of Laplacian (∇2𝜌) values 
and electron densities (𝜌), Bader’s QTAIMs has been adopted in this work [131–133]. QTAIM 
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calculations were performed using AIM2000 software [134]. Wiberg bond index (WBI) was stated as 
[135,136]: 
WBI = ∑ 𝑃𝑗𝑘
2
𝑘   = 2𝑃𝑗𝑗  −  𝑃𝑗𝑗
2                                                                                                                             (5) 
where 𝑃𝑗𝑗  and 𝑃𝑗𝑘 are charge densities in atomic orbital and density matrix elements, respectively. Higher 
values of WBI meant stronger covalent characters and had close correlation to bond order. 
It can be seen in Fig. 2-2 that, in the studied complexes, oxygen, nitrogen and hydrogen atoms in 
DOX molecules formed bonds with oxygen, carbon and hydrogen atoms in CNTs and ƒ-CNTs. Hence, 
the studied structures were stabilized by various intermolecular HB interactions. To study this fact in 
more detail, intermolecular HB energies (𝐸𝐻𝐵) were calculated using Espinosa method [137–139], as 
summarized in Table 2-4. This method assumed a simple relationship between potential energy density 
(𝑉𝐵𝐶𝑃) and 𝐸𝐻𝐵 energy at a critical point corresponding to intermolecular HB contact as: 
𝐸𝐻𝐵 =1/2 𝑉𝐵𝐶𝑃                                                                                                                                                 (6) 
As given in Table 2-4, DOX molecules could participate in a wide range of intermolecular 
conventional (N-H…O, N…O-H, O…O-H and O-H…O) and nonconventional (H…C and O… H) HBs 
with NTs. 
The results listed in Table 2-4 reveal that 𝐸𝐻𝐵 values for O…H, O-H…N, O…H-N, and O-H…O 
in systems containing ƒ-CNTs were considerable. Detailed evaluation of C and E complexes in systems 
containing ƒ-CNT1 and ƒ-CNT2, respectively, revealed that the magnitude of HB interaction is more 
than complex A with non-functionalized surface. Hence, one could conclude that HB interaction was 
among the most important factors in the stability of the studied complexes. 
To better understand the nature of intermolecular interactions between CNT and DOX molecules, 
QTAIM  calculation was applied. This theory analyzes the electron density of various characteristic 
points, especially bond critical points (BCPs), to obtain electron density (ρBCP) and Laplacian (∇ρBCP
2 ) 
values to determine the strength and characteristic of bonds, respectively. Tale 4 lists the values of 
kinetic electron density (GBCP), local potential electron energy density (VBCP), total electron energy 
density (HBCP), Laplacian (∇ρBCP
2 ), and electron densities (ρBCP)  for all structures. Total local energy 
density at BCP was stated as [140]: 
HBCP = GBCP + VBCP                                                                                                                                       (7) 
In the above equation, VBCP and GBCP are local potential and kinetic energy densities at BCP, 
respectively. At critical points, where ρBCP = 0, local kinetic energy density can be stated as: 
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GBCP = 2.871 (ρBCP
5
3 ) + (1.6 × ∇ρBCP
2 )                                                                                                              (8) 





2 ) − (2 × GBCP)                                                                                                                       (9) 
All parameters in the above equation are stated in atomic units (a.u). 
Table 2-4. The topological parameters, Lagrangian kinetic (GBCP) and potential (VBCP) electron energy 
densities (all in a.u.), Laplacian (∇2ρBCP), electron density(ρBCP), total electron energy density (HBCP) along 
with its two components, hydrogen bond energy (EHB, in Kcal/mol), intermolecular distance (R) in (Å) for the 
intermolecular interactions between DOX and NTs in the considered complexes in aqueous solution, calculated 
using Espinosa method 
Model Bond 𝜌𝐵𝐶𝑃  ∇
2𝜌𝐵𝐶𝑃  𝐺𝐵𝐶𝑃  𝐻𝐵𝐶𝑃  𝑉𝐵𝐶𝑃  𝐸𝐻𝐵   R 
 
A 
H104..…O151 0.009921 -0.014423     -0.011438 -0.002985 0.008452 2.652 2.339 
H107…..O155 0.010605 -0.014668     -0.011735 -0.002933 0.008801 2.761 2.486 
C74…....H176 0.001286 -0.001408     -0.000998 -0.000410 0.000588 0.184 3.551 
 
B 
H158….O216 0.036464 -0.030016     -0.038337  0.008321 0.046658 14.639 1.825 
  C2-C11…H223 0.008232 -0.007343     -0.006169 -0.001173 0.004995 1.567 2.749 





O159……H203 0.052766 -0.033907     -0.052000 0.018092 0.070093 21.991 1.654 
H166……O214 0.040821 -0.033361 -0.043607 0.010246 0.053854 16.896 1.777 
H158……N224* 0.044723 -0.023634 -0.036025 0.012391 0.048417 15.191 1.826 
O157……H225 0.014680 -0.018808 -0.016508    -0.002299 0.014208 4.457 2.221 
   C21…...H236 0.005458 -0.005030 -0.004003    -0.001033 0.002970 0.932 2.876 




H163…...O191 0.034228 -0.030900 -0.037444 0.006544 0.043988 13.801 1.823 
O159……H203 0.028766 -0.028382 -0.031988 0.003606 0.035595 11.168 1.903 
O160……H189 0.013044 -0.016373 -0.013911 -0.002461 0.011450 3.592 2.295 





H176……O226 0.063898 -0.033364 -0.057837 0.024472 0.082310 25.824 1.573 
O171……H209 0.011311 -0.014770 -0.012010 -0.002759 0.009251 2.902 2.379 
O170…...H233 0.008310 -0.011406 -0.008865 -0.002541 0.006324 1.984 2.496 
O168……H235 0.010049 -0.014954 -0.011945 -0.003001 0.008937 2.804 2.318 





H175……O203 0.044394 -0.033581 -0.046180 0.012599 0.058779 18.442 1.698 
H175……O196 0.016408 -0.026065 -0.022950 -0.003114 0.019835 6.223 2.126 
O168……H205 0.012512 -0.018985 -0.015938 -0.003046 0.012892 4.045 2.198 
H176…...N234* 0.060019 -0.025008 -0.044987 0.019978 0.064965 20.383 1.679 
  C23-C24…..H236 0.002769 -0.003393 -0.002444 -0.000949 0.001495 0.469 3.117 
 
G 
O168……H218 0.038412 -0.031339 -0.040530 0.009191 0.049721 15.599 1.766 
H175…...O201 0.040062 -0.033132 -0.043023 0.009891 0.052915 16.602 1.736 
H176……O224 0.056356 -0.032451 -0.053127 0.020676 0.073803 23.155 1.633 
• * Represents bonds formed in gas phase 
Rozas et al. [141] classified interaction character based on the function of 𝐻𝐵𝐶𝑃 with ∇𝜌𝐵𝐶𝑃
2  and the 
signs and values of ∇𝜌𝐵𝐶𝑃
2  determine the nature of bond such that negative values indicate covalent 
bonding and positive values show non-covalent and electrostatic bonds. Negative values of ∇𝜌𝐵𝐶𝑃
2  
indicate high electron density and concentration of charge in this nuclear region. If ∇𝜌𝐵𝐶𝑃
2 > 0.1, ionic 
bond is formed, if ∇𝜌𝐵𝐶𝑃
2 ≅ 0.1 covalent bond is formed and if ∇𝜌𝐵𝐶𝑃
2 ≤ 0.01 weak Van der Waals 
hydrogen bond is formed. For bonds with covalent nature and high strength, we would have 𝑉𝐵𝐶𝑃 >
 𝐺𝐵𝐶𝑃 which is a function of intermolecular distance R. Also, comprehensive analysis of the values of 





| revealed that when 0.1 ≤ 𝛼 ≤ 0.5, covalent bond is formed, when 0.5 ≤ 𝛼 ≤ 1, ionic 
covalent bond is formed in which covalent bond tends to be polarized and has partially ionic nature, and 
when 𝛼 > 1, by assuming negative values for ∇𝜌𝐵𝐶𝑃
2 , weak covalent bond is formed and by assuming 
positive values for this term, we have electro static bond. 
Hence, calculated electron density of DOX/NTs complexes revealed that intermolecular hydrogen 
bonds had low 𝜌𝐵𝐶𝑃 (0.001 to 0.06 a.u) and negative ∇𝜌𝐵𝐶𝑃
2  values (-0.001 to -0.033 a.u) in aqueous 
phase. The values of  ∇𝜌𝐵𝐶𝑃
2  and 𝜌𝐵𝐶𝑃 were in the acceptable range of HB interactions [142–144] proving 
the presence of closed-shell interactions in the studied complexes. Therefore, these factors with negative 
or positive HBCP values at intermolecular H-bonding indicated that the studied complexes had partially 
electrostatic and partially covalent natures simultaneously. Electron densities at BCPs of N…H, O…H, 
and C…H in DOX/ƒ-CNT and DOX/P-CNT systems respectively, had good correlation with energy 
strength 𝐸𝐻𝐵. Therefore, high electron densities corresponded to higher values of 𝐸𝐻𝐵 and vice versa 
(Table 2-4). The maximum values of electron density (𝜌𝐵𝐶𝑃) and 𝐸𝐻𝐵 for ƒ-CNT1 and ƒ-CNT2 systems 
obtained for C and E complexes at O159…H203 and H176…O226 contact points were 0.052766 a.u, 
21.991 Kcal/mol and 0.063898 a.u, 25.824 Kcal/mol, respectively. The amount of 𝐸𝐻𝐵 parameter 
illustrate bond strength. Generally, shorter intermolecular distance between drug atoms and surface 
atoms of NT’s, enhance the strength of 𝐸𝐻𝐵. The data presented in Tables 2-4 revealed that in complex 
C, the length of intermolecular O-H⋯H hydrogen bond between 𝑂159 …. 𝐻203 was shorter than that 
between 𝐻166 …. 𝑂214 and in complex F, 𝐻175 …. 𝑂203 hydrogen bond length was shorter than 𝐻175…. 
𝑂196; therefore, shorter conjugations formed stronger H-bonds. Also, more detailed investigation of 
complex F in Table 2-4 showed that two dominant hydrogen bonds were formed between O203 of drug 
and H175 of CNT as well as N234 and H176 of CNT with 𝐸𝐻𝐵 values of 18.442 and 20.383 Kcal/mol, 
respectively, while system E with one bond was more stable. These results complied well with those 
obtained in the previous section for the most stable configuration, i.e. complex F. It was concluded that 
higher electron densities at BCP corresponded to higher strengths of intermolecular hydrogen bonds. To 
emphasize this, the relationships between 𝜌𝐵𝐶𝑃 and ∇𝜌𝐵𝐶𝑃
2  versus 𝐸𝐻𝐵 at intermolecular interaction are 
determined and shown in Figs. 2-3 and 2-4, respectively. The correlation coefficients of these 
dependencies were very close to 0.99. 
In addition, Fig. 2-5 shows the molecular diagrams of CNT, DOX, and selected most stable 
complexes C and F, which revealed the positions of all critical points and bond paths between attractors 
in DOX/NTs systems. Red dots on the bonds showed bonds BCP points and yellow dots represent rings 
critical points in structural rings. The positions of critical points on bonds greatly depended on 
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electronegativity. The critical point of the bond is closer to the atom with lower electronegativity. Fig. 
2-6 shows electron density Laplacian contour maps of all critical points in all studied complexes. 
 
Fig. 2-3. Correlation between calculated 𝜌𝐵𝐶𝑃 and 𝐸𝐻𝐵 energies at BCP 
 
 
Fig. 2-4. Correlation between calculated ∇𝜌𝐵𝐶𝑃
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Fig. 2-6. Contour maps of electron density (left) and electron density Laplacian (right) for all critical points 
in all complexes obtained from DFT calculations 
2. 3. 1. 4. Thermodynamic Properties 
Thermodynamic parameters can provide deeper understanding on essential energy changes due to 
adsorption; therefore, these parameters should be comprehensively investigated. The Gibbs free 
energy function [145], of a system at constant temperature was defined as: 
∆𝐺 = ∆𝐻 − 𝑇∆𝑆                                                                                                                           (10) 
Where the variations of Gibbs free energy (∆G), entropy (∆S), and enthalpy (∆H) of all complexes 
at 1 atm and 298 K were determined to describe adsorption process in PCM (Table 2-5). Negative 
standard enthalpy or give out energy in the form of heat ∆H < 0, and positive entropy or increase in the 
disorder of the system ∆S > 0 values meant thermodynamically favorable and spontaneous formation 
of E, F, G complexes in aqueous phase. On the other hand, the WB97XD level of theory predicted that 
adsorption process had exothermic enthalpy and, positive T∆S values for complexes containing ƒ-CNT2 
indicated stable entropy variations during complex formation. 
It was found that the formation of A, B, C, and D complexes at WB97XD functional entropically 
was not favorable, but the quantity of Gibbs free energy ∆𝐺 which reflect the balance between two 
potential was negative. Therefore, concluded that the adsorption process for all studied systems was 
thermodynamically favorable and spontaneous. Complexes with higher values of relative standard 
Gibbs energy of formation were more stable while those with lower relative standard energy of 
formation were more unstable. 
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Table 2-5. Calculated thermodynamic properties (∆G, ∆H, and T∆S), all in Kcal/mol 
Complex ∆G ∆H T∆S 
A -8.197 -12.589 -4.392 
B -24.079 -38.014 -13.935 
C -24.424 -38.290 -13.866 
D -24.779 -37.685 -12.906 
E -54.199 -69.671 15.472 
F -53.167 -67.418 14.251 
G -55.003 -69.060 14.057 
2. 3. 1. 5. Electronic Properties 
Molecular orbitals (MO) including lowest unoccupied molecular orbital (LUMO) and highest 
occupied molecular orbital (HOMO) were also calculated for the valuated systems. The gaps in the 
energy levels (Eg) of a system was calculated as: 
Eg = ELUMO − EHOMO                                                                                                                                     (11) 
Also, we calculated quantum molecular descriptors  such as electronic chemical potential (µ) [146], 
energy gap (eV), dipole (µ ֯) (debye), electronegativity (X) [147], global softness (s), global hardness (ɳ) 
[148], and electrophilicity index (ω) [149] of NTs, DOX and evaluated complexes to describe the 
chemical reactivity and stability of different configurations using the following equations and the 
obtained results are listed in Table 2-6. 
μ = (ELUMO + EHOMO)/2                                                                                                                              (12) 
ɳ = (ELUMO − EHOMO)/2                                                                                                                               (13) 
ω = μ2/2ɳ                                                                                                                                                      (14) 
Electrophilicity index (ω) is a key factor, and the value of this factor is high in most electrophilic 
systems. Electrophilicity index is weighted as a degree of the energy decrement of the chemical species 
because of the maximum rate of electron passing from ambience and provides insight about structural 
reactivity, stability, and toxicity of chemical species. LUMO and HOMO iso levels of NTs and DOX 
are shown in Fig 2-7. For P-SWCNT, LUMO and HOMO were uniformly delocalized throughout NT 
sidewall along C-C bonds, parallel and perpendicular to CNT axis, respectively. However, for ƒ-CNTs 
with carboxyl and hydroxyl groups, the distribution of HOMO and LUMO orbitals on the surface of 
CNT was non-uniform (Fig 2-7). It is noteworthy that orbitals at functionalized points had higher 
accumulation and strength than pristine CNTs. Fig 2-7 presents the distributions of LUMO and HOMO 
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of DOX molecules on its aromatic ring and on C or O atoms as well as C-C, C-O and O-H bonds. It was 
seen in Fig 2-8 that, in the complexes with the highest stability (C and F), HOMO was distributed on 
DOX molecule and LUMO was localized on the surface of ƒ-CNTs, indicating that electrons were 
transferred from DOX to ƒ-CNTs. Hardness and energy gap values of NTs were lower than those of 
DOX. This meant that NTs were more polarizable than DOX and therefore, NTs could accept electrons 
from DOX molecules. 
Table 2-6. Dipole moments (µ֯) (Debye), HOMO (𝐸𝐻𝑂𝑀𝑂) and LUMO (𝐸𝐿𝑈𝑀𝑂) energies, gap energy (𝐸𝑔), 
quantum molecular descriptors, chemical hardness (ɳ), chemical softness (S), chemical potential (µ), 
electronegativity (X), electrophilicity index(𝜔), (all in eV) calculated at WB97XD/6-31+G(d, p) level for DOX, 
SWCNT, ƒ-SWCNT and different DOX molecules adsorbed by pristine and functionalized (6,6) armchair 
SWCNT 
COMPLEX Phase (µ ֯) EHOMO ELUMO Eg (ɳ) (S) (µ) (X) (ω) 
DOX 
PCM 4.294 -6.911 -0.194 6.717 3.358 0.297 -3.552 3.552 1.879 
GAS 3.701 -6.857 -0.129 6.728 3.364 0.297 -3.493 3.493 1.815 
SWCNT 
PCM 0.000 -5.771 -1.733 4.038 2.019 0.495 -3.752 3.752 3.486 
GAS 0.000 -5.597 -1.552 4.045 2.022 0.494 -3.574 3.574 3.158 
ƒ-CNT1 
PCM 12.749 -6.345 -2.050 4.295 2.147 0.465 -4.197 4.197 4.102 
GAS 6.024 -6.168 -1.859 4.309 2.154 0.464 -4.013 4.013 3.738 
ƒ-CNT2 
PCM 32.688 -5.563 -2.480 3.083 1.541 0.649 -4.021 4.021 5.247 
GAS 2.711 -5.446 -2.027 3.419 1.709 0.585 -3.736 3.736 4.083 
A 
PCM 10.791 -5.701 -1.663 4.038 2.019 0.495 -3.682 3.682 3.357 
GAS 8.432 -5.436 -1.411 4.025 2.012 0.497 -3.423 3.423 2.911 
B 
PCM 9.041 -6.340 -2.055 4.285 2.142 0.466 -4.197 4.197 4.112 
GAS 5.447 -6.103 -1.807 4.296 2.148 0.465 -3.955 3.955 3.641 
C 
PCM 11.382 -6.372 -2.099 4.273 2.136 0.468 -4.235 4.235 4.199 
GAS 7.170 -6.234 -1.931 4.427 2.213 0.452 -4.082 4.082 3.764 
D 
PCM 14.223 -6.336 -2.068 4.268 2.134 0.468 -4.202 4.202 4.137 
GAS 8.350 -6.276 -2.001 4.275 2.137 0.468 -4.138 4.138 4.006 
E 
PCM 22.505 -5.425 -2.466 2.959 1.479 0.676 -3.945 3.945 5.261 
GAS 6.121 -5.512 -2.094 3.418 1.709 0.585 -3.803 3.803 6.532 
F 
PCM 22.474 -5.384 -2.433 2.951 1.475 0.678 -3.908 3.908 5.178 
GAS 3.689 -5.454 -2.020 3.434 1.717 0.582 -3.737 3.737 4.066 
G 
PCM 23.154 -5.410 -2.463 2.947 1.473 0.678 -3.936 3.936 5.260 
GAS 4.822 -5.354 -1.914 3.440 1.720 0.581 -3.634 3.634 3.839 
Table 2-6 presents the values of LUMO, HOMO and E𝑔 for all studied models in both phases 
revealing the variations of E𝑔 for P-CNT, ƒ-CNT1 and ƒ-CNT2 complexes in aqueous phase in the range 
of 4.038 eV, (4.268–4.285 eV) and (2.947-2.959), respectively. Low values of E𝑔 meant low kinetic 
stability and high chemical reactivity for all of evaluated systems. Systems containing carboxylated 
CNTs had the lowest E𝑔 values and the difference of E𝑔 values in aqueous and gas phases for this system 
was higher than those of other complexes. Also, E𝑔 had higher values in gas phase which indicated that 
in this phase, chemical reactivity was lower and kinetic stability was higher. It is also noteworthy that 
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lower values of gap energy indicated semi-conductive behavior of structure. The data presented in Table 
2-6 revealed slight variations of 𝐸𝐿𝑈𝑀𝑂 and 𝐸𝐻𝑂𝑀𝑂 for all complexes before and after adsorption which 
were almost the same as LUMO and HOMO energies of isolated NTs in two phases. Therefore, 
electrophilicity, energy gap, softness and hardness were not remarkably changed in various complexes 
indicating that upon the adsorption of DOX onto NTs, the electronic characteristics of the evaluated 
complexes were not changed significantly. As such, charge transfer between DOX and NTs molecules 
was insignificant. In drug delivery systems, this is an ideal interaction since drug molecules could be 
simply released from NT surface. Furthermore, the values of chemical potential NTs before and after 
DOX adsorption were negative, indicating that the investigated complexes were stable. 
More comprehensive evaluation of the electrophilicity index and chemical potential of the 
considered fragments confirmed that electron flow occurred spontaneously from DOX to NTs, because 
electrons being transferred from higher chemical potential. As an electrophilic species, NTs can accept 
electrons from drug molecules during adsorption process. Also, it was observed that the dipole moments 
of the evaluated configurations were improved by phase change from gas to aqueous. This difference 
was significant in ƒ-CNT2 systems. Hardness ɳ values revealed that DOX molecules were harder than 
NTs and drug hardness was found to decrease by adsorption. In addition, this work confirmed that the 













Fig. 2-7. Orbital diagrams of HOMO and LUMO in optimized (a) DOX, (b) SWCNT, (c) ƒ-CNT1, (d)   
ƒ-CNT2 
46 |P a g e  
 
 
Fig. 2-8. Orbital diagrams of HOMO and LUMO in most stable complexes (C and F) in gas phase 
In this work, the thermodynamic and kinetic aspects of the interaction between NTs (i.e., the 
acceptor, A) and DOX (i.e., the donor, B) have also been studied. The global NTs-DOX interaction can 
be calculated using ∆N parameter which shows the fractional number of electrons transferred from 





                                                                                                                                                  (15) 
where η and μ are the chemical hardness and potential of acceptor (A) and donor (B), respectively. 
Positive values of ∆N indicate that charge was transferred from B to A and A acted as electron 
acceptor, while negative values of ∆N indicated that charge was transferred from A to B and A acted as 
electron donor. Sarmah et al. [150] proposed comprehensive decomposition analysis of stabilization 
energy (CDASE) method and found that stabilization energy (SE) and its different components as well 
as charge transfer can be employed to find the most stable adduct obtained by noncovalent interactions 
[151,152]. Overall stabilization energy could be expressed as: 
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where ɳA and μAare the chemical hardness and potential of acceptor (A), respectively. Similarly, and 
indicate the same parameters for the donor (B). The changes of individual energy components (i.e., 
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It is noteworthy that the individual interaction of NTs and DOX molecules, including individual 
energy changes of acceptor (∆EA(B)) and donor (∆EB(A)), calculated and results are summarized in Table 
2-7. 
Table 2-7. The values of charge transfer (∆N), individual energy change of acceptor (∆EA(B)) , individual 
energy change of donor ( ∆EB(A)), and overall stabilization energy ( ∆ESE(AB)), (all in eV) within reacting DOX 
drug molecule and NTs in aqueous and gas phases 
Fragment ∆N ∆EA(B) ∆EB(A) ∆ESE(AB) 
PCM GAS PCM GAS PCM GAS PCM GAS 
P-CNT 0.0371 0.0150 -0.1378 -0.0534 0.1341 0.0527 -0.0037 -0.0007 
ƒ-CNT1 0.1172 0.0942 -0.4771 -0.3684 0.4326 0.3439 -0.0445 -0.0245 
ƒ-CNT2 0.0957 0.0479 -0.3777 -0.1770 0.3553 0.1712 -0.0224 -0.0058 
In this study, the kinetic properties of DOX-CNT interaction have been evaluated using ∆EB(A), 
whereas ∆EA(B) and ∆ESE(AB) were employed to examine the thermodynamic stability of products. First, 
we assumed NT and DOX molecules and acceptor (A) and donor (B), respectively. ∆N values for 
DOX/NT complexes were positive which confirmed that electron flow direction was from DOX to NT. 
It is noteworthy that charge transfer rate in studied complexes in aqueous phase was higher than that in 
gas phase. Negative ∆EA(B) value confirmed that the complex was more stable than isolated NT and 
DOX molecules. However, positive ∆EB(A) value showed energetically promising process; in other 
words, electrons were transferred from DOX as donor to NT as acceptor. Finally, negative ∆ESE(AB) 
value revealed the thermodynamic stability of the complexes. 
2. 3. 1. 6. Density of States Analysis 
Density of states (DOS) of a system shows state number in the intervals of unit energy. In an isolated 
system, energy levels are discrete, and the concept of DOS is not clear. However, if discrete energy 
levels are artificially expanded to the curve, DOS diagram can act a powerful tool to describe the 
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composition of orbitals [153–155]. The curve of partial density of states (PDOS) can be applied to 
visualize orbital compositions. PDOS function of fragment A can be stated as: 
𝑃𝐷𝑂𝑆𝐴(𝐸) = ∑ 𝐸𝑖,𝐴𝑖 𝐹(𝐸 − 𝑖)                                                                                                                    (19) 
where 𝐸𝑖,𝐴 is the composition of orbital i and fragment A and 𝑖 shows single-particle Hamilton 
eigenvalue set [156]. Visualization of PDOS spectra was performed by Multiwfn 3.6 software [157] 
using the data obtained from WB97XD/6-31+G(d, p) level of theory. 
System DOS defines state number per energy interval at each energy level that available for 
electrons. Higher DOS values at a certain energy level denote the availability of several states for 
occupation. Zero DOS shows that at that energy level, there are no states available for occupation. As 
can be seen in Table 2-6, and Fig 2-9, comparison of 𝐸𝑔 values showed that after DOX adsorption onto 
NTs, the energy gap of nanotube was not considerably changed. According to Fig 2-9 the total density 
of states (TDOS) plots of complexes were almost similar to that of PDOS NTs. The only difference is 
that, comparison of peak heights at the highest energy level showed that DOS level in functionalized 
CNT systems were higher than those of system A which showed that CNTs had more states for 
occupation. Also, unlike complex A, no hybridization occurred between CNT PDOS and TDOS which 
indicated more favorable physical adsorption in these systems. 
It is noteworthy that energy gap was the energy range of a molecule in which no electron states 
existed. In DOS graphs, 𝐸𝑔 is energy difference between conduction (LUMO) and valence (HOMO) 
levels. This corresponded to the energy required for outer shell electron release from its orbital around 
the nucleus to become a movable charge carrier capable of moving freely in material matrix. Therefore, 
𝐸𝑔 was a major factor in the determination of electrical conductivity in a material. Our results showed 
that the functionalization of pristine CNTs with carboxyl group decreased energy gap from 4.038 to 
3.083 eV. Therefore, this type of functionalization shifted the behavior of CNT toward semiconductors 
while functionalization with hydroxyl increased energy gap by 0.257 eV and insulator properties of 
CNTs. 
To study DOX adsorption effect on electronic structures of functionalized CNTs, PDOS and TDOS 
of P-CNT COMPLEX (complex A) and the most stable configurations (C and F) are shown in Fig. 2-9. 
PDOS plot mainly shows fragment orbital compositions contributing to molecular orbitals. PDOS 
results of the most stable complexes revealed that the main contribution to HOMO orbital came from 
DOX molecules (Fig. 2-9). On the other hand, the value of LUMO for CNTs was higher than that of 
DOX molecule; i.e., it participates in adsorption process through its LUMO orbital. As presented in Fig 
2-9, no considerable hybridization occurred during adsorption process between DOX and NT’s orbitals. 
Also, comparison of curves showed that the possibility of this hybridization was decreased according to 
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the following order f-CNT2  <   f-CNT1  <  P-CNT which confirmed the physical adsorption of drug 






































































Fig. 2-9. The calculated total and projected electronic density of states (TDOS and PDOS) (a) complex A, (b) 
complex C, (c) complex F 
2. 3. 1. 7. NBO Analysis 
NBO analyses were also conducted to determine charge delocalization and orbital interactions at 
the same DFT theory level [158,159]. For better understanding intermolecular interactions in the 
evaluated complexes, NBO analyses were conducted which provided a great amount of information on 
the strength and nature of intermolecular interactions in terms of local orbital interactions and their 
second-order perturbation energy (𝐸(2)). Table 2-8 lists the results obtained from NBO analyses on all 
investigated complexes. These analyses also demonstrated significant charge transfer between DOX and 
functionalized CNT molecules in DOX/ƒ-CNTs interaction unlike pristine CNT which was 
insignificant. NBO analyses showed that DOX tended to transfer of electrons to NTs during adsorption 
process. Therefore, in all of the evaluated complexes, drug molecules acted as donor and NTs acted as 
acceptor, and charge transfer occurred in DOX→ NTs direction. The calculated second-order 
perturbation interaction energy (𝐸(2)) for DOX/CNT, DOX/ƒ-CNT1 and DOX/ƒ-CNT2 systems were 
in the ranges of 0.12-2.95 and 0.06-42.34 and 0.05-69.37 Kcal/mol, respectively. The obtained results 































𝐸𝑔= 2.951 eV 
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than that of P-CNT complex and corresponding values for DOX/ƒ-CNT2 configurations were higher 
than those of DOX/ƒ-CNT1 complexes. It was witnessed that electron transfer was a key factor 
facilitating the adsorption of the molecules on the adsorbent. It was also found that higher energy values 
(𝐸2) for DOX adsorption onto CNT resulted in a greater extent of interaction between DOX and CNT 
molecules. 
The theoretical findings of this work illustrated that in hydroxylated CNT systems at configurations 
B, lone electron pair of O216 in drug molecule acted as donor through H158 atom on O-H group of the 
functionalized CNT, and ƒ-CNT1 acted as  acceptor in intermolecular charge transfer interactions at 
energy levels of 13.01 and 14.64 Kcal/mol in gas and aqueous phases, respectively. In complex C, lone 
pairs of atoms O159, O214 and N224 in DOX acted as donor through H203, H166 and H158 atoms of 
ƒ-CNT1 as an acceptor respectively.  The 𝐸(2) values of these pairs are summarized in Table 2-8 for 
aqueous and gas phases. The  strongest intermolecular interaction was observed for configuration  C 
which, compared to other complexes in hydroxylated CNT systems, had the highest total charge transfer 
energies of 36.43 for and 42.34 Kcal/mol for O-H and N-H in gas and aqueous phases, respectively. In 
complex D, the lone pair of O191 atom in DOX acts as a donor with lone pair H163 atom of ƒ1-CNT 
as acceptor with energy values of 16.81 and 10.34 Kcal/mol in aqueous and gas phases, respectively. 
The data provided in Table 2-8 showed that the highest 𝐸(2) energies were obtained for complexes 
E, F and G in systems with carboxylated CNTs. In complex E, a lone bond was formed between atom 
O226 of drug molecule as donor and H176 of carboxyl on CNT as acceptor with 𝐸(2)energies of 50.16 
and 50.41 Kcal/mol in aqueous and gas phases, respectively. In system F, two dominant lone bonds 
occurred between N234 of drug as electron donor and H176 of CNT as electron acceptor as well as 
O203 of drug and H175 of CNT with 𝐸(2)energies of 69.3 and 66.46 Kcal/mol as well as 23.83 and 
21.78 Kcal/mol in aqueous and gas phases, respectively. The obtained results showed that system F had 
the highest stability which confirmed the results obtained in the previous section. In complex G, three 
dominant bonds were formed between O-H----H and H----O in drug and ƒ-CNT2 molecules two of 
which, i.e. those between O224 and O201 as well as H176 and H175 with energy values of 55.29 and 
20.51 Kcal/mol in aqueous phases, respectively, drug molecule acted as electron donor and CNT acted 
as electro n acceptor while in the other bond between O168 of carbonyl group on CNT acted as electron 
donor and H218 of drug acted as electron acceptor which had 𝐸(2) energy levels of 13.29 and 13.85 
Kcal/mol in aqueous and gas phases, respectively. According to 𝐸(2) energy levels in this model, it was 
concluded that generally drug molecules acted as electron donor and CNT acted as acceptor. 
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Table 2-8. The second-order perturbation energy (𝐸(2)), Kcal/mol, corresponds to the charge flow between the 












LP (1) O 151          𝜎*(1) C 61 - H 104 2.95 --- 
LP (1) O 151          𝜎*(1) C 49 - H 102 --- 2.53 




LP (1) O 216 LP*(1) H 158 14.64 13.01 
    𝜎 ∗(1) C 2-C 11 π*(1) H 223 0.35 0.31 






LP (2) O 159 LP*(1) H 203 36.43 21.49 
LP (2) O 214 LP*(1) H 166 23.71 --- 
LP (1) N 224 LP*(1) H 158 --- 42.34 
LP (3) O 157 π*(1) H 225 0.21 --- 
LP (1) O 157               𝜎*(1) N 224 - H 225 1.40 --- 
       𝜎 (1) C 21 - C 22 π*(1) H 236 0.06 --- 





LP (1) O 191 LP*(1) H 163 16.81 10.34 
LP (2) O 159 LP*(1) H 203 --- 21.49 
LP (3) O 160 π*(1) H 189 0.50 0.27 
LP (3) O 159 π*(1) H 205 0.15 0.14 





LP (2) O 226 LP*(1) H 176 50.16 50.41 
LP (1) O 171              𝜎*(1) C 208 - H 209 1.15 2.16 
LP (3) O 170 π*(1) H 233 0.12 0.17 
LP (1) O 168               𝜎*(1) N 234 - H 235 2.46 2.56 





LP (1) O 203 LP*(1) H 175 23.83 21.78 
LP*(1) H 175 π*(1) O 196 0.05 --- 
LP*(1) H 205 π*(1) O 168 0.06 --- 
LP (1) N 234 LP*(1) H 176 69.37 66.46 





LP (2) O 224               𝜎*(1) O 170 - H 176 --- 36.97 
LP (2) O 224 LP*(1) H 176 55.29 --- 
LP (1) O 201               𝜎*(1) O 167 - H 175 --- 18.53 
LP (1) O 201 LP*(1) H 175 20.51 --- 
LP (1) O 168 LP*(1) H 218 13.29 13.85 
2. 3. 1. 8. Molecular Electrostatic Potential (MEP) 
Molecular electrostatic potential (MEP) at a certain point near a molecule indicates net electrostatic 
effect generated at that point through total distribution of charge in the molecule. MEP is an important 
factor when studying reactivity describing that an approaching electrophile would be attracted to 
negative sites (in which the effect of electron distribution is dominant). The significance of MEP is 
because it gives the shape and size of the molecule and determines its negative, neutral and positive 
electrostatic potential regions as color grading and provides a powerful tool in investigating the 
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relationship between molecular structure and  its physiochemical characteristics [160,161]. Different 
electrostatic potential values at surface were shown in different colors such that red shows the most 
negative electrostatic potential, green shows zero potential regions, blue shows the most positive 
electrostatic potential. Potential was increased in the order of red<orange<yellow<green<blue. 
According to MEP plots presented in Fig. 2-10, O atoms were red (negatively charged) and N and H 
atoms were intensively blue (positively charged). This meant that the most intensive electron transfer 
occurred from electropositive atoms (N and H) to the electronegative one (O). However, as can be seen 
in the most stable complexes (C and F) Due to their electropositive property, N and H atoms in DOX 





   
(b) (c) (d) 




(e) (f) (g) 
Fig. 2-10. Molecular electrostatic potential (MEP) surfaces of (a) DOX (b) P-CNT (c) ƒ-CNT1 (d) ƒ-CNT2 
(e) complex A (f) complex C and (g) complex F obtained at WB97XD/6-31+G (d,p) level 
2. 4. Conclusion 
In this work, to investigate the nature of interactions between active points of anticancer drug DOX 
and outer surfaces of pristine and functionalized CNT molecules in aqueous and gas phases using DFT 
calculations. Geometrical analyses showed that bond distance between the atoms of drug molecule 
before and after being adsorbed onto the outer surface of CNT was not significantly changed which 
indicated its stability. Negative values of adsorption energy in the investigated complexes in aqueous 
and gas phases showed that the interactions between DOX and CNT molecules were favorable and the 
process was physisorption  and exothermal. Also, the values of these energies showed that the 
functionalization of CNT, especially with –COOH functional group, improved the adsorption of drug 
molecule onto CNT and therefore, intermolecular hydrogen bonds have important role in the stability 
of physisorption. The results also showed that adsorption process was more stable and favorable in gas 
phase. QTAIM calculations showed that the nature of bonds was covalent and there was a direct relation 
between the distance and strength of bond which was even stronger in systems with functionalized 
CNTs. Also, the electronic properties and descriptors of the considered systems were calculated in 
aqueous and gas phases and the obtained results showed that the functionalization of CNTs with –COOH 
and –OH groups gave them semiconductor and metallic properties, respectively. Negative enthalpy and 
Gibbs free energy values in the studied systems indicated that adsorption process was exothermic and 
thermodynamically favorable. Also, NBO calculations showed that adsorption was achieved through 
electron transfer from drug molecule to CNT. Also, DOS results showed that, unlike pristine CNTs, 
there was not adequate hybridization between drug and CNT molecules in functionalized systems, which 
indicated stable adsorption process. 




Investigate the importance of mechanical properties of SWCNT on 
Doxorubicin anti-cancer drug adsorption for medical application: a 
molecular dynamic study 
 
3. 1. Introduction 
Most relevant research works have focused on targeting cancer cells and avoiding healthy cells to 
reduce side effects. Nanoparticles such as micelle, liposome, biocompatible polymers, gold nano-cages 
and nanotubes for delivering drugs to suffering infected cells have also found wide applications 
[49,162,163]. Doxorubicin is one of the chemotherapy drugs and a compound of anthracycline. It 
intercalates between base pairs in the helical structure of DNA and prevents its replication of the 
synthesis of protein. It also stops or slows cancer cell growth by blocking the activity of topoisomerase 
enzyme II, which is crucial for cell division and growth. Doxorubicin is a toxic compound that can 
damage healthy cells, in addition to cancer cells, in the bloodstream. Therefore, nano-carriers play a 
critical role in improving the application of chemotherapy drugs [164]. 
Identification and detection of doxorubicin in human plasma is of critical importance. Fauso et al. 
[165] used CNT as a biosensor for the detection of glucose in human plasma. Graphene-based 
electrochemical sensors have been successfully fabricated and applied for the detection of doxorubicin 
[110,166]. Natural bond orbital (NBO) is one of the most efficient and popular methods in quantum 
calculations. NBO is in fact calculated by bond orbitals, which show the maximum electron density of 
two- and three-centered bonds in the most precise manner. In this method, atomic orbitals are 
transformed into molecular orbitals using different quantum calculations. The idea of NBO was first 
introduced by Lowdin in 1995 [167]. The interactions of anticancer drug penicillamine and simple and 
functionalized carbon nanotubes were investigated using DFT and NBO methods [168]. It should be 
kept in mind that the diameter of SWCNTs had to be suitable to be able to easily penetrate cell membrane 
with the lowest energy barrier and cell damage. CNTs with diameters of larger than 4 nm have larger 
energy barriers,  and  therefore cannot uptake cell membrane spontaneously [92]. SWCNTs with a 1-2 
nm outer diameter have variable length and unique optical and electrical properties [169]. Therefore, 
the narrowest CNTs, which can capsulate drug molecules, are convenient carriers to be used in DDS. 
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In this work, we first found the electrical properties of drug atoms and small prototype CNT samples 
using DFT and NBO methods. Then, by using molecular dynamic simulation, CHARMM27 force field 
and the data obtained using the quantum method, the mechanism of the adsorption of drug by the CNT 
was determined by considering the variations of mechanical properties of CNT with four different 
diameters of 21.54, 24.24, 26.93, 29.62 Å, three different lengths 4, 4.5, and 5 nm, and three chirality 
types of armchair, chiral, zigzag with chiral (20, 20), (22, 18), and (34, 0) respectively and three different 
temperatures of 305, 310 and 315 K. Finally, the best option was introduced by analyzing interaction 
energy variations and the contact pairs between drug molecules and CNTs. We also investigated the 
plots of drug molecule radial distribution around SWCNT, relative intensity of peaks, and adsorption 
and encapsulation capacity. 
3. 2. Quantum mechanics calculation 
3. 2. 1. Electronic properties 
In this section, for obtain charge distribution a pristine carbon nanotube with chirality (6, 6), length 
13Å, and 132 carbon atoms saturated at the terminal position with hydrogen atoms was created as a 
prototype using the Nanotube Modeler 1.7 software and Doxorubicin (DOX) molecule was taken from 
DRUGBANK website. [170] The molecular structure of, and the optimized structure and size of DOX 
is depicted in Fig. 3-1a. DFT calculations were implemented using the Gaussian 09 package Frisch et 
al. [171] with 6.31G(d,p) B3LYP basis set for optimization and executed by NBO [158,172] method for 
all structures, which is an optimal grade of theory for extracting accurate and reliable results. The 
chemical structure and obtained charge distribution are shown in Fig. 3-1b. Charge density distribution 
maps of DOX and CNT are represented in Figs. 3-2 a and b, respectively. 
       
(a)                                                                       (b) 
Fig. 3-1. a) Optimized doxorubicin structure and size (oxygen red, carbon grey, hydrogen white, nitrogen blue) 
b) Chemical structure and charge distribution of DOX 
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(a)                                                                                (b) 
Fig. 3-2. NBO charge distribution map for a) Doxorubicin b) (6,6) pristine SWCNT 
3. 3. MD simulation 
In this section, molecular dynamic simulation has been used for the investigation of the effects of 
the mechanical properties of carbon nanotubes on its interaction with DOX molecules. All simulations 
were performed by using GROMACS 5.1.4 software [173] and CHARMM27 force field. Simulations 
were performed on a cubic box with dimensions 10, 10 and 12 nm, along x, y and z directions, 
respectively, with periodic conditions along all three directions. CNT is located in the center of the box 
along the z-axis, surrounded with 15 randomly oriented DOX molecules at a distance of 2 to 3 nm away 
from the surface of CNT, as shown in Fig. 3-3. This structure was created with Packmol software. Then, 
the simulation box was fully filled with water molecules using transferable intermolecular potential with 
three points (TIP3P) water model [174]. 
Before each simulation, the energy of the system was minimized and thermal equilibrium was 
achieved at a constant temperature of 310 K for 1 ns with V-rescale model. Then, constant pressure of 
1 bar was applied for 6 ns with Parrinello-Rahman algorithm, and all bonds of structures molecule in 
systems were constrained by using Linear Constraint Solver (LINCS) algorithm [175]. Long-range 
electrostatic interactions were obtained using particle-mesh Ewald method [176] with a cut-off radius 
of 1.4 nm. Lennard Jones (L-J) interactions were applied for the calculation of Van der Waals 
interactions with a cut-off radius of 1.4 nm. Interaction time step was set to 2 fs. CNT force field 
parameters were taken from reference [177], and the topology of DOX molecules with the interaction 
parameter corresponding to the CHARMM27 force field was taken from the Swiss Param server [178]. 
All systems were neutral with zero charge by adding chloride ions to solvation, and the simulation 
duration for all systems was 100 ns. First, 4 armchair CNTs with different lengths of 21.54, 24.24, 26.93 
and 29.62 and chiral vectors of (16, 16), (18, 18), (20, 20), and (22, 22) with a fixed length of 4.5 nm 
was chosen. Then, the selected armchair (20, 20) CNT with length 4.5 nm was employed to investigate 
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the effect of temperature on adsorption phenomenon at three different temperatures of 305, 310 and 315 
K. To evaluate the effect of CNT length on the adsorption of DOX molecules also armchair chiral vector 
(20, 20) CNT with length 4.5 nm was selected and the obtained results were compared with those 
obtained for samples with lengths 4 and 5 nm. Finally, two more simulations were performed to 
investigate the effect of nanotube chirality on the adsorption of drug molecules. To do so, two CNT 
samples with chirality (22, 18) and zigzag (34, 0) with similar diameter and length were selected. The 
main goal of this work was to investigate the free interaction of DOX molecules and CNT. Also, for the 
precision of the obtained results, free Gibbs energy was calculated using the linear interaction energy 
(LIE) method [179]. It is noteworthy that graphical images were created with VMD software. 10 entirely 
different systems were employed for simulations, and the summary of these systems are given in Table 
3-1. 
 
Fig. 3-3. The initial structure of system 
Table 3-1. Summary of set up systems 








Number of atoms 
in simulation box 
1 (16,16) 21.54 4.5 310 117736 
2 (18,18) 24.24 4.5 310 117738 
3 (20,20) 26.93 4.5 310 117790 
4 (22,22) 29.62 4.5 310 117689 
5 (20,20) 26.93 4.0 310 117675 
6 (20,20) 26.93 5.0 310 117590 
7 (20,20) 26.93 4.5 305 117790 
8 (20,20) 26.93 4.5 315 117790 
9 (22,18) 26.97 4.5 310 117737 
10 (34,0) 26.43 4.5 310 117624 
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3. 3. 1. Evaluate the equilibration state 
Firstly, the equilibrium states of the studied systems were determined by monitoring factors such 
as temperature, pressure, and density, as well as total energy and root-mean-square deviation (RMSD) 
curves. Figs. 3-4(a)-(c) show temperature, pressure and density curves of system 3 during 6 ns 
equilibration, respectively, where oscillations were at constant temperature 310 K, pressure 1 bar, and 
density 989𝐾𝑔/𝑚3. Root-mean-square deviation (RMSD) measures the average distance between the 
atoms (usually backbone atoms) of superimposed proteins. It is noteworthy that RMSD calculations can 
also be applied to non-protein molecules, such as small organic molecules. In this study, to determine 
the time required for the systems to achieve equilibrium, RMSD analysis and total energy was applied. 
Therefore, systems number 3, 6, and 9 (as a selected candidate systems) was kept under equilibrium 
conditions for 20 ns. As shown in Fig. 3-5a, oscillations  
For selected systems after about 4 ns, the value of RMSD oscillated about 5 nm and fully 
equilibrated at 6 ns. The final trajectory of 6 ns in equilibration stage was used for the remaining stages 
of MD. The total energy oscillation for system 3 were plotted for DOX/SWCNT in water against 
simulation time, as shown in Fig. 3-5b. The results showed that the total energy in complex had a 
negative value, indicating more system stability. Therefore, our simulation systems achieved 
equilibrium at this time. For the other samples, similar diagrams were obtained and 6 ns was selected as 
the preferred equilibration time for all systems. 
 
(a) 






Fig. 3-4. Equilibration plots of a) Temperature b) Pressure c) Density of system 3 versus 6 ns 
equilibration time 






Fig. 3-5. a) RMSD plot of DOX molecules for selected systems at 20 ns equilibration time b) Total energy 
plot of system 3 in water medium versus simulation time  
3. 4. Results and discussion 
3. 4. 1. Effect of CNT diameter 
In this section, for the evaluation of the effect of CNT diameter increases on drug adsorption, first 
four CNTs with diameters 21.54. 24.24, 26.93 and 29.62 Å ֯ with chiralities (16, 16), (18, 18), (20, 20) 
and (22, 22), respectively, were selected to be simulated in the same simulation box at 310 K for 100 
ns. The results obtained from L-J interactions, the number of contacts between CNT and DOX molecule 
are shown in Figs. 3-6 and 3-7 respectively as can be seen at the beginning of the diagram of system 4, 
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Van der Waals interaction energy level between DOX molecules and CNT was more negative than other 
systems with lower diameters. Following this, the main amount of released energy was decreased until 
25 ns, and then gradually and lightly decreases for up to 70 ns, after which it was fixed, which is steady 
state and the number of contacts also confirm that. It could be said that at 70 ns, all systems were 
saturated in terms of energy exchange. Also, the energy level at the end of simulation reached its 
maximum, and it was evident that energy level difference between drug molecules and CNT was directly 
related to the increase in CNT diameter. Because by the increase of nanotube diameter, the surface 
available for drug molecule get more suitable for interaction. Therefore, it could be concluded that in 
the case of CNT with larger diameters, DOX molecules and CNT formed stronger bonds. As can be 
seen, the CNT–DOX VdW interaction energies have negative values which indicate that the drug 
adsorption is exothermic and reveal that DOX molecule spontaneously moves toward the carrier. 
 
Fig. 3-6. Van der Waals energies between CNT and DOX molecules as a function of simulation time 
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Fig. 3-8. Electrostatic energies between DOX molecules and CNT as a function of simulation time 
   
 
   
 
(a) (b) (c) (d) 
Fig. 3-9. Molecular dynamic snapshots of DOX molecules adsorbed on CNT at the end of simulation (a) (16, 
16) CNT, (b) (18, 18) CNT, (c) (20, 20) CNT (d) (22, 22) CNT. Water molecules are not shown for clarity. 
(Upper pictures show front views and lower pictures show lateral views) 
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Electrostatic interaction energy is much less than VdW energy because the surface charge of pristine 
CNT is neutral and is almost zero. It can be seen from Fig. 3-8 that the electrostatic energy levels in 
CNTs exhibited a higher oscillation with larger diameters than those of CNTs with smaller diameters. 
The average numerical values of the energies are shown in Table 3-2. Comparison of the energy 
contributions shows that the VdW interaction has more effect on the adsorption of the drug molecule 
onto carrier surface than electrostatic interaction. Also, in this work, DOX-DOX Van der Waals 
interaction energy values were also calculated, and the precise numerical values are presented in the 
Table 3-2. Values were in the range of 84.804 to 241.623 KJ/mol for systems with different diameters 
which showed that, regardless of the effect of CNT diameter, drug molecules made somehow random 
interactions during the simulation. 
Fig. 3-9 shows the final conditions of samples at the end of the simulations. The upper and lower 
rows show the front and lateral views, respectively. It is also evident in Fig. 3-8 that, in all systems, all 
15 DOX molecules in the box were adsorbed onto the CNT surface or into the inside. The details of the 
number of adsorbed drug molecules are shown in Table 3-3. As can be seen in Table 3-3, system 3 with 
CNT (20, 20) could capsulate 7 drug molecules inside. It could be concluded that armchair CNTs (20, 
20) had the highest potential for encapsulating DOX molecules which showed that the cavity size of 
CNT (20, 20) had the most suitable conditions with DOX structure for entering. 
Other systems, except system 1, could capsulate at least 2 DOX molecules inside the CNT. It could 
be concluded that, due to narrower cavities of CNTs with chiralities lower than (16, 16), these nanotubes 
had a significantly reduced ability to encapsulate DOX molecules inside their cavities due to the size of 
DOX molecules. The amounts of Gibbs energy of the solution and accessible solvent surface had a linear 
relationship with the increase of CNT diameter. The amount of Gibbs free energy obtained from LIE 
method also verified the correctness of our findings, as presented in the fourth column of the diagram. 
In the LIE method, Gibbs free energy was calculated using the following equation: 
∆𝐺𝑏𝑖𝑛𝑑= α (𝑉  𝑏𝑜𝑛𝑑
 𝐸𝐿   ̶  𝑉 𝑓𝑟𝑒𝑒
𝐸𝐿 ) + β (𝑉  𝑏𝑜𝑛𝑑
 𝑣𝑑𝑤   ̶  𝑉 𝑓𝑟𝑒𝑒
𝑣𝑑𝑤 )                                                                                               (1) 
Where 𝑉  𝑏𝑜𝑛𝑑
 𝐸𝐿  and 𝑉  𝑏𝑜𝑛𝑑
 𝑣𝑑𝑤    represent Van der Waals and electrostatic interaction energies between 
solvated CNT and DOX based on the simulation results of all systems, and 𝑉 𝑓𝑟𝑒𝑒
𝐸𝐿  and 𝑉 𝑓𝑟𝑒𝑒
𝑣𝑑𝑤  are Van der 
Waals and electrostatic interaction energies between DOX molecules in water, respectively, performed 
in another simulation (where only water and drug molecules were present in simulation box). The results 
obtained using α = 0.5 and β = 0.16 values correlated well with experimental data [180]. Free solvation 
energy (FES) and solvent accessible surface area (SASA) values are calculated and presented in the fifth 
and sixth columns of Table 3-2 respectively, which showed that increase of the nanotube surface area 
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increased the access of solvation. Also, increase of CNT diameter increased free energy of solvent (FES) 
therefore CNT solubility is reduced. 




















1 -1367.27 -3.0284 95.639 -748.722 494.405 86.103 
2 -1622.69 -8.3511 179.163 -748.722 554.439 96.775 
3 -1808.33 -9.9886 132.804 -748.722 624.842 107.238 
4 -1900.33 -10.377 241.623 -748.722 684.041 119.184 
 
Table 3-3. Number of DOX molecules encapsulated inside and on the surface of CNT 
System Inner outer Net charge of system 
before neutralized 
1 0 15 +2 
2 2 13 +3 
3 7 8 +3 
4 3 12 +3 
Radial distribution function (RDF) is a commonly used and useful analysis method applied for the 
calculation of radial distance, or the probability of the presence of two or a group of atoms around the 
mass center of a certain particle. In this work, we aimed to calculate how far DOX molecules were from 
the center of the CNT axis during last 10 ns the adsorption process at 100 ns. Using this analysis, we 
could observe that DOX molecules in which system were capsulated inside the CNT and had shorter 
distances from nanotube radius. 
Fig. 3-10 shows the RDF diagrams of all four systems. This figure illustrates that more interactions 
occurred within a radius of 3 nm from nanotube axis. Overall, two main peak groups occurred neared 
1.5 nm. The left peak group indicates that interaction peaks occurred inside CNTs, and the right peak 
group shows that interaction peaks occurred outside the CNTs. The first peak was obtained for system 
3 at a radial distance of 0.5 nm. The second peak was obtained for system 2 at 0.7 nm from the nanotube 
axis, the third peak was again obtained for system 3 but this time with higher density and 0.8 nm away 
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from CNT axis which showed the highest strength among corresponding systems. These results were 
consistent with the number of molecules inside CNTs in system 3 and comparison of peak strengths 
inside and outside the CNTs showed that the bonding strength of drug molecules with the inside of CNT 
(20, 20) was higher than that with its outside. Also, the fourth one was obtained for system 4 at the 
distance of 1.2 nm from the nanotube axis. Based on the obtained values, it could be concluded that, in 
systems 2, 3 and 4, the distance of some drug molecules was shorter than CNT radiuses, which showed 
the encapsulation of drug molecules inside the nanotubes. In system 1, just one peak occurred (located 
at 1.6 nm), which was much larger than the nanotube radius which indicated the lack of encapsulation 
capability in this system. It is evident that in system 1, DOX molecules were not encapsulated inside the 
CNT. In addition, by comparing the strength of the peaks, it could be realized that at the distance of the 
obtained peak, DOX molecules had the strongest bond with CNT. 
 
Fig. 3-10. Radial distribution functions (RDFs) of DOX molecules around CNT (inside and outside) at 310 K 
Diffusion coefficient (𝐷𝑃) is suitable for the determination of the amount of diffusivity of a particle 
in a system and can be by calculated using the slope of mean-square displacement (MSD) versus 
simulation time. In this work, to obtain the diffusivity of drug molecules (DP) adsorbed to CNTs in 








                                                                                                                         (2) 
When simulation time was assumed to be t, diffusion coefficient of a particle can be calculated 
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Since all systems were simulated in three dimensions, it was considered that n=3. The value and 
curve of diffusion coefficient for DOX molecules interacting with CNTs with different diameters are 
shown in Fig. 3-11. As can be seen in the figure, the value of DP was decreased with the increase of 
CNT diameter. This difference was negligible for CNTs (20, 20) and (22, 22). In other words, it could 
be said that the diffusion coefficient of drug molecules had an adverse relation with CNT diameter. 
 
Fig. 3-11. Mean square displacement (MSD) plot of DOX molecules around of CNTs with different diameters 
at 310 K 
3. 4. 2. Effect of temperature 
The mean body temperature of a healthy human is about 310 K, which can be 5 K lower or higher 
(Hypothermia, Hyperthermia) due to different factors such as fever or other diseases. Therefore, in this 
section, to better understand the effect of drug adsorption onto CNT surface, system 3 at 310 K was 
selected as the reference system sample with a difference of 5 degrees lower and higher, i.e., 305 K 
(system 7) and 315 K (system 8), chosen for the comparison with the reference simulation system. It is 
seen in graphical Fig. 3-12 that at 305 K, the ability of CNT to encapsulate DOX molecules was 
decreased. The results shown in Fig. 3-13 indicated that Van der Waals energy level between DOX 
molecules and CNT after 30 ns reached a higher constant value as temperature increases. 
After 65 ns, VdW energy levels of the system at 310 K became equal to those at 315 K which shows 
that they have reached similar energy levels. With the increase of temperature, the kinetic energy of 
complex and the number of contacts are also increased. The plots in Fig. 3-14 show that in the system 
with temperature 315K, at 15ns the number of contacts in was much higher than that with temperatures 
305K and 310K; in other words, with the adsorption of more drug molecules and within 2.5 ns, almost 
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38 ns. In the system with temperature 315 k, a decrease was observed in contact number at 40 ns which 
was due to the separation of some drug molecules from CNT surface because of the weakness and 
instability of the system which were then adsorbed by CNTs again immediately resulting in the increase 
of contact number. As can be seen in the diagram, after 65 ns, oscillations in the curve reached a constant 
value which showed system stability. 
The numerical average values of Van der Waals energy shown in Table 3-4 for systems 3 and 8 
were almost the same, but had a higher difference from the average Van der Waals energy level of 
system 7 at 305 K. Therefore, it could be concluded that temperatures above 310 K were better choices 
for the adsorption process. Note that column 3 in Table 3-4 shows that DOX molecules at lower 
temperatures had weaker Van der Waals energy with each other; they did not tend to agglomerate any 
more. It is worth mentioning that temperature variation had an insignificant effect on the Gibbs free 
energy of the solvation. 
   
 
  
(a) (b) (c) 
Fig. 3-12. Molecular dynamic Snapshots of the simulated systems with 15 DOX molecules and armchair (20, 
20) CNT at three temperatures: (a) 305 K, (b) 310 K, and (c) 315 K (water molecules are not shown in figure 
for clarity). (upper pictures show front views and lower pictures show lateral views) 
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Fig. 3-13. Van der Waals energies between DOX molecules and armchair (20, 20) CNT, at three temperatures 
305, 310 and 315 K as a function of simulation time 
 
Fig. 3-14. The number of contacts plot versus simulation time in water solution 
Table 3-4. Free energy values of systems with different temperatures obtained from molecular dynamic 



















7 -1519.97 -2.162 88.951 -697.215 614.749 107.357 
3 -1808.33 -9.988 132.804 -748.722 624.842 107.238 
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Fig. 3-15 shows the diagram of electrostatic force between CNTs and drug molecules in systems 
with temperatures of 305, 310 and 315 K. According to Fig. 3-15, the energy of electrostatic bonds was 
in the range of 20 to -48 KJ/mol and the lowest value was obtained for system 7 at 305 K which was -
34 KJ/mol and in system 3 (310 K), the diagram showed that the maximum negative energy was obtained 
at 48 ns and reached the maximum negative value of -48 KJ/mol, which indicated the strongest 
electrostatic bond  in studied different systems with thermal conditions. It is notable that the low 
fluctuation above 0 in systems was caused by DOX molecules after adsorption inside an outer of CNT 
influenced by other molecules interaction that agglomerate and form temporary VdW interactions by H 
bonds. This may influence EL between DOX and CNT. 
 
Fig. 3-15. Electrostatic energies between DOX molecules and CNT at three temperatures 305, 310 and 315 K as 
a function of simulation time 
Fig. 3-16. shows the RDF diagram of the three systems at temperatures 305, 310 and 315 K that 
extracted from last 10 ns simulation time. As can be seen, the first peak for all systems was appeared 
below 1.5 nm which showed that in all three systems, capsulation had taken place. Comparing peak 
strengths showed that systems 3, which can capsulated 7 drug molecules, had the strongest peak at 
distance 0.8 nm from CNT axis and comparing its strength with the second peak proved the higher 
strengths of bonding on the inner surface of CNT. In system 8 at 315 K, the bonding strength of drug 
molecule and CNT was almost similar in the inside and outside of the CNT. However, in system 7, as 
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could be seen, the strength of the second peak was much higher than that of the first peak which showed 
that the bonds formed on the outside were stronger. 
According to Table 3-5, at the end of the simulation at 100 ns, system 7 with temperature 305 K 
was able to encapsulate only one DOX molecule inside the CNT. However, in systems 3 and 8 at 
temperatures 310 and 315 K, 7 and 4 DOX molecules were encapsulated in CNT, respectively. It can 
be concluded that, generally increase of temperature increased the ability of CNT to adsorb DOX 
molecules  into CNT.  However, at 310 K, which is the normal body temperature, it had a better 
performance in the encapsulation of drug molecules compared to that at higher temperature of 315 K 
which showed that it was the optimum temperature for DOX encapsulation. 
 
Fig. 3-16. Comparison of the radial distribution function of DOX around (20, 20) CNT at three temperatures of 
305, 310 and 315 K 
Table 3-5. Number of DOX molecules encapsulated inside and on the surface of CNT 
System Inner outer Net charge of system 
before neutralization 
7 1 14 +3 
3 7 8 +3 
8 4 11 +3 
To determine the effect of temperature on the diffusion coefficient 𝐷𝑃 of drug molecules, calculations 
were performed and curves were drawn; the corresponding values are shown in Fig. 3-17. As can be 
seen, at 310 K, drug molecules had the lowest diffusion coefficient during 100 ns of simulation. It could 
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Fig. 3-17. Mean square displacement (MSD) plot of DOX molecules around CNT at different temperatures 
3. 4. 3. Effect of CNT length 
Like CNT diameter, CNT length can also significantly affect the spontaneous adsorption process 
of DOX molecules to CNTs. Therefore, in this work, CNTs of system 3 with armchair (20, 20) and 
length 4.5 nm were applied as the reference sample. Then, two other CNTs with 4 (system 5) and 5 nm 
(system 6) in length were used for comparison. 
In Fig. 3-18, Van der Waals energy between DOX molecules and CNTs had the maximum negative 
value at the end of simulation time. As shown in Fig. 3-19 the number of contacts also suggested these 
increases. Based on L-J energy values between DOX and CNT in the first column of Table 3-6, with 
increase in the length of nanotube, the numerical value of covalent energy was increased from -1585.47 
KJ/mol for CNTs with a length of 4 nm to -1964.78 KJ/mol for those with a length of 5 nm. The average 
value of electrostatic energy between DOX molecules and CNT molecules during 100 ns for system 6 
with CNT 5 nm in length had the highest value, (-19.801 KJ/mol) which was significantly higher than 
other systems. Meanwhile, DOX molecules had the highest interaction with each other in system 6. In 
addition, it could be seen that the value of DOX-DOX Gibbs free energy obtained from LIE method (in 
which only drug and solution molecules were present in the simulation box) was almost similar to that 
obtained for Gibbs FES. It could be concluded that system 6 had the highest yield in the process of 
simultaneous adsorption of DOX. Based on the results presented in the sixth column of Table 3-6, the 
value of solvent accessible surface area (SASA) for longer CNTs were higher. The increase of surface 
area of CNT made it more polarized and provides a higher surface area available for solvent; therefore, 
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Based on the results of the snapshots presented in Fig. 3-20 and the number of encapsulated DOX 
molecules in Table 3-7 at the end of 100 ns simulation time, it was seen that, in all studied systems, all 
15 DOX molecules, were adsorbed by CNTs. CNT 4.5 nm and 5 nm in lengths in system 3 and 6 had 
the highest ability to encapsulate drug molecules such that 7 and 5 DOX molecules were encapsulated 
inside in CNT respectively. Therefore, it could be concluded that increase of nanotube length increased 
the capacity of DOX storage inside nanotubes. 
 
Fig. 3-18. Van der Waals energies between DOX molecules and (20, 20) CNT with three different lengths 
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(a) (b) (c) 
Fig. 3-20. Molecular dynamic snapshots of DOX molecules adsorbed on armchair (20, 20) CNT with 
different lengths (a) 4 nm (b) 4.5 nm, (c) 5 nm (water molecules are not shown in figure for clarity). (Top 
pictures show front views and below pictures show lateral views) 
 
 
Fig. 3-21. Electrostatic energies between DOX molecules and CNT at three lengths of 4.0, 4.5 and 5.0 nm as a 
function of simulation time 
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As evident in the diagram of Fig. 3-21, in system 5, the interaction of electrostatic energy between 
nanotube and DOX molecules during 100 ns simulation time reached maximum negative values of -60 
KJ/mol at some points. Then, due to equilibration after 73 ns, the diagram oscillated around the values 
of 0. For system 3, the maximum value of -48 KJ/mol was reached at 48 ns, and then, after 80 ns, it 
tended towards 0. In system 6, in the time range of 55-73 ns, EL interactions with maximum value of -
65 KJ/mol were observed in the system. After that, small oscillations around 0 were witnessed which 
indicated that the system in the equilibrium state. The average numerical values of these diagrams were 
illustrated in column 2 of Table 3-6. 
Fig. 3-22 shows the RDF diagram of DOX molecules around nanotube for three (20, 20) CNT types 
with different lengths as can be seen in RDF diagram. The strongest first peak in system 3 appeared in 
0.8 nm from the axis of nanotubes 4.5 nm in length. The second peak for system 6 appeared at distance 
0.9 nm and the third peak of the system with zigzag nanotube occurred at the distance of 1.1 nm from 
CNT axis. Comparison of the strength of peaks for these three systems indicated that system 5 with 
nanotube length of 4 nm adsorbed DOX molecules with a far lower strength than longer nanotubes in 
systems 3 and 6. However, it is noteworthy that according to RDF results, nanotubes with length 4.5 nm 
had better performance in the encapsulation and adsorption of DOX molecules. The strength of the 
second peaks was almost similar for all three systems which showed that the strengths of surface 
interactions on nanotubes were almost the same. As shown in Fig. 3-23 Diffusion coefficient 𝐷𝑃 values 
of drug molecules of all three studied systems were between 0.0268 and 0.0909× 10−5𝑐𝑚2/𝑠  where 
the values of systems 3 and 6 were close. 
 
Fig. 3-22. Comparison of the radial distribution function of DOX molecules around (20, 20) CNT with three 
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Table 3-6. Free energy values of systems with different lengths of CNTs obtained from molecular dynamic 


















5 -1585.47 -14.669 169.843 -748.722 601.714 104.326 
3 -1808.33 -9.988 132.804 -748.722 624.842 107.238 
6 -1964.78 -19.801 331.494 -748.722 735.539 124.863 
Table 3-7. Number of DOX molecules encapsulated inside and on the surface of CNT 
System Inner outer Net charge of system 
before neutralization 
5 1 14 +3 
3 7 8 +3 
6 5 10 +3 
 
Fig. 3-23. Mean square displacement (MSD) plot of DOX molecules around CNTs with different lengths 
3. 4. 4. Effect of CNT chirality 
To determine the effects of CNTs chirality on the adsorption of DOX drug molecules, system 3 
with armchair (20, 20) and a length of 4.5 nm was chosen as the reference sample. Then, two system 
types of chiral CNT (22, 18) (system 9) and zigzag (34, 0) (system 10) with similar length and diameter 
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the same conditions for 100 ns. It is worth mentioning that three chiralities were different in the 
arrangement of carbon atoms. Fig. 3-24 shows the structural difference between these three types of 
CNT. 
After the simulation, it was observed that CNT chirality had significant effects on the adsorption of 
DOX molecules. As seen in Fig. 3-25, after achieving equilibrium under constant pressure after 6 ns 
(i.e. in the beginning of the simulation), CNTs with chirality (22, 18) achieved a higher energy level 
than the armchair and zigzag CNTs, i.e. -1050 KJ/mol, which was 350 KJ/mol higher than the energy 
level of system 3 with armchair CNTs and 750 KJ/mol higher than the energy level of system 10 with 
zigzag CNTs. However, according to the data summarized in Table 3-8, during 100 ns, system 3 with 
an armchair CNT had most average value VdW interaction energy and electrostatic potential between 
DOX molecules and CNT, while CNT in system 10 (with zigzag structure) had a much lower interaction 
energy than the other two systems. In this system, L-J energy between DOX molecules was also low, 
which indicated that DOX molecules had a weak interaction with each other. As can be seen in Fig. 3-
26, at the end of equilibration process, the system with chiral nanotubes (22-18) had the highest number 
of bond-forming contacts and had more tendency to form contact bonds with drug molecules.  
However, after 40 ns and until the end of simulation, with the stabilization of systems, contact number 
for all three systems with armchair nanotubes was higher than that of system 9 with chiral nanotubes. 
Therefore, armchair nanotubes had more capability in the adsorption of drug molecules. 
It could be concluded from Fig. 3-27 snapshots and the number of adsorbed DOX molecules represented 
in Table 3-9, that system 10 with zigzag CNT had not encapsulating ability. Therefore, chiral and 
especially armchair CNTs, were more suitable choices in this work. These differences in drug molecule 
storage capability and interactions can be attributed to different atomic arrangements and atomic charges 
in the terminal sections of CNTs for each structure. 
 
Fig. 3-24. Different structural types of CNT 
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Fig. 3-25. Van der Waals energies between DOX molecules and CNT for three different types of CNT 
chiralities 
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(a) (b) (c) 
Fig. 3-27. Molecular dynamic snapshots of DOX molecules adsorbed on CNT at the end of simulation (a) 
(20, 20) CNT (b) (22, 18) CNT (c) (34, 0) CNT. (Water molecules are removed for clarity). (Top pictures 
show front views and below pictures show lateral views) 
 
 
Fig. 3-28. Electrostatic energies between DOX molecules and CNT for three different types of CNT chiralities 
as a function of simulation time 
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According to the numerical average values of electrostatic interactions of diagrams in Fig. 3-28 
which are precisely given in column 2 of Table 3-8, for armchair nanotube, a value of -9.988 KJ/mol 
was obtained, which was higher than that of chiral (-7.660 KJ/mol) and zigzag nanotubes (-5.188 
KJ/mol); this indicated strong electrostatic interactions in armchair nanotube type compared to other 
nanotubes. RDF diagrams of three sample systems containing CNTs with different chirality are shown 
in Fig. 3-29. These diagrams indicated that the first peaks appeared at a distance of 0.5 nm to 0.8 nm for 
system 3, which was the strongest peak among these three systems. The second peak belonged to system 
9, which appeared at a distance 0.7 to 1.1 nm and it was significantly weaker than the peak of system 3. 
Therefore, according to the above findings, it could be concluded that DOX molecules in system 3 
formed stronger bonds with armchair CNTs. In system 10, only one peak occurred at a distance of higher 
than CNT radius. This revealed that zigzag CNTs were not able to capsulate DOX molecules in their 
cavity. Comparing the strength of second peaks of above systems revealed that bond strength for system 
3 with 8 molecules adsorbed on the outside of the CNT was slightly lower than that of system 10 with 
all 15 CNTs adsorbed on it which revealed the bonding strength of drug molecule on the outer surface 
of zigzag CNT was much lower than that of armchair CNT. 
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Table 3-8. Free energy values of systems with different chiralities obtained from molecular dynamic simulation 



















9 -1739.41 -7.660 267.814 -748.722 654.475 113.359 
3 -1808.33 -9.988 132.804 -748.722 624.842 107.238 
10 -1274.53 -5.188 111.288 -748.722 635.033 114.282 
  
Table 3-9. Number of DOX molecules encapsulated inside and on the surface of CNT 
System Inner outer Net charge of system 
before neutralization 
9 2 13 +5 
3 7 8 +3 
10 0 15 +3 
As can be seen in Fig. 3-30, diffusion coefficient 𝐷𝑝values of drug molecules in systems with zigzag 
CNTs was significantly higher than systems 3 and 9 with armchair and chiral CNTs, respectively. By 
the evaluation of the results obtained in this section and previously studied systems, it could be 
concluded that lower values of 𝐷𝑝 of drug molecules were more suitable for this application. 
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3. 5. Conclusions 
In this work, using molecular dynamic simulation, we investigated the effects of the variations of 
environmental thermal conditions and mechanical properties of CNTs on the adsorption of DOX drug 
molecules and encapsulation ability of carbonaceous nano-carriers. The negative value of VdW energy 
suggested that the loading of DOX to the pristine SWCNT is spontaneous and exothermic and the VdW 
interaction between DOX and CNT significantly is more than EL interaction. The number of contacts 
investigated that reveal that has directly related to VdW energy for all systems. In this work, 10 different 
systems were simulated. First, four nanotube types with different respective diameters of 21.54, 24.24, 
26.93, and 29.62 Å were selected. The obtained results showed that increase of diameter increased the 
VdW interaction and system with CNT (20, 20) had the highest encapsulation capability of DOX drug 
molecules inside cavity. In order to evaluate the effect of temperature differences on DOX adsorption 
process, 3 different temperature systems were investigated. To do so, a CNT armchair (20, 20) with 
length of 4.5 nm and equilibrium temperature of 310 K (which was equal to normothermia) was selected. 
Then, two systems with ±5 K temperature differences were simulated, and the obtained results showed 
that the human body temperature of 310 K was suitable for better drug delivery. Also, three different 
systems were tested to determine the effect of CNT length on drug adsorption process. To do so, CNTs 
armchair with chirality (20, 20) and length of 4.5 nm at 310 K were considered as a reference system, 
and two systems with similar characteristics but different lengths (of 4 nm and 5 nm) were simulated. 
The obtained results showed that the increase in CNT length had a significant effect on the 
adsorption and encapsulation of DOX molecules, and CNTs with a length of 4.5 nm was a better choice. 
Finally, to evaluate the effect of CNT chirality on DOX adsorption phenomenon, 3 different systems 
with armchair, chiral and zigzag nanotubes of (20, 20), (22, 18) and (34, 0), respectively, with similar 
diameters and lengths were simulated at 310 K. It was witnessed that chiral and especially armchair 
CNT, were far superior choices to those with zigzag structures. In addition, radial distribution plots of 
drug molecules around SWCNT, relative between intensity of peaks and adsorption has investigated. In 
this work, lower diffusion coefficient value of drug molecules was more suitable in the studied systems. 
A direct relationship was observed between FES and nanotube surface area; therefore, increase of CNT 










Prediction of doxorubicin drug delivery using single-walled carbon 
nanotube carrier through POPC cell membrane in the presence and 
absence of ethanol molecules 
 
4. 1. Introduction 
Biological membranes play important roles in cell life. One of the prominent functions of cell membrane 
is transferring various particles. These particles can be ions, drug molecules and other small molecules 
that are essential for cell survival. The membrane of cell can also act as a protective barrier against the 
passage of large molecules such as carbohydrates and amino acids as well as highly charged ions. Many 
cavities, canals and pumps can be found inside cell membrane, making it capable of exchanging with 
external environment [181,182]. 
This approach could be promising in increasing the permeation of drug molecules in DDS, which is 
being widely developed nowadays. One of the challenges in DDS systems is the lack of biocompatibility 
and insolubility of drug molecules, which can be solved by using biocompatible carriers. Nanocarbon 
particles are one of these materials that, because of their unique intrinsic and mechanical characteristics, 
have become very popuar among many scientists working on improving DDS systems [183,184]. 
Steered molecular dynamic (SMD) simulations are applied to investigate SWCNT permeability through 
biological membranes [185]. In this study, POPC membrane (phosphatidylcholine) with chemical 
formula 𝐶42𝐻82𝑁𝑂8𝑃 was used to simulate cell membrane. In biophysical experiments, POPC is one of 
the important phospholipids and has been utilized to study different subjects. POPC is also used in cell 
membrane mimicking systems such as Nanodiscs [186]. It is available commercially at Avanti polar 
lipids Inc. and naturally exists in eukaryotic cell membranes [187]. The study of the interaction between 
SWCNT and human cells, especially cell membranes, is very important in developing biological systems 
containing carbon nanoparticles in DDS. 
Phospholipids are the main cell membrane constituents, have superior biocompatibility and are known 
for their amphiphilic structure, which gives them emulsifying, self-assembly and wetting properties 
[188]. 
Alcohol consumption, especially when habituated, can increase periodontitis risk in the long term. 
Ethanol can be found as the main component of alcoholic products in the saliva and blood of people 
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who have consumed alcohol [189,190]. When ethanol enters human body, it is distributed by 
bloodstream and passes through blood-brain barrier and enters the brain within 5 minutes and its effects 
up to 10 Minutes [20]. Many researches have been conducted to find the intracellular effects of ethanol 
[191–193]. However, research on extracellular effects, especially in DDSs, is insufficient. Therefore, in 
this theoretical study, due to the similar effects of ethanol on CNT/DOX complex penetration 
mechanism in cell membrane, it was examined by SMD simulation. 
4. 2. Computational method 
In this section, the effect of the presence of ethanol molecules in extracellular environment on the 
permeability of CNT/DOX complex to lipid bilayer membrane is investigated. The two systems are 
examined with systems specifications shown in Table 4-1. Both systems consist of an armchair carbon 
nanotube (20,20) with length 50 nm containing 4 DOX molecules capsulated inside it and a phospholipid 
cell membrane with 128 lipid molecules per leaflet. In Fig. 4-1 schematic components of the system are 
shown. All components of the system are placed inside the simulation box with dimensions of 10 × 10 
× 25 nm and both systems are filled with water solution, such that in system No. 2, the top solution of 
the membrane (extracellular) is randomly 40 ethanol molecules are dispersed. It should be noted that 
the simulation steps were performed using steered molecular dynamics (SMD) method. 
 Force probe or SMD simulations apply force to protein molecules for the manipulation of their 
structures by pulling them along certain degrees of freedom. These investigations could be applied to 
show structural variations in proteins at atomic level. From a mechanistic point of view, SMD provides 
efficiets insight into dynamic and transient interactions to complement static descriptions achieved from 
X-ray crystallography experiments. SMD is generally employed for the simulation of events such as 
mechanical stretching and unfolding [185,194] and several significant SMD applications are in 
biomolecular sciences and drug discovery. 
4. 2. 1. MD simulations 
In this chapter, CNT/DOX complex is located more than 1.5 nm away from membrane and after 
equilibration, it is pulled vertically towards the membrane at a constant speed of 10 nm/ns with a of 
1000 KJ/mol. (𝑁𝑚)2 tensile force . Figure 4-2 shows the stages of nanotube passage through 
membranes. It is noteworthy that the atomic charge of nanotube atoms and drug molecules was obtained 
by DFT method using NBO method and B3LYP 6-31G (d, p) functions of Gaussian software. POPC 
cell membrane structure is taken from (http://www.charmm-gui.org). 
All MD simulations are performed in NPT ensemble using GROMACS 5.1.2 software [195]. Parrinello–
Rahman barostat and Berendsen thermostat algorithm with isotropic pressure coupling are employed, 
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respectively, to keep pressure (1 bar) and temperature (310 K) constant. Particle-mesh Ewald approach 
uses calculated long-range electrostatic interaction [176,196]. Cutoff radius for the considered approach 
is 1.4 nm, simulation time step is 2 fs and LINCS algorithm is applied to sustain the rigidity of water 
molecules. The charges of all studied systems were adjusted at zero by adding sodium and chlorin ions. 
Before MD simulations,the energy of  each system is minimized and then equilibrated  for 7 ns. 
Transferable intermolecular potential with three points (TIP3P) water model [197] is used to solve all 
simulated systems. CHARRM36 force field is  applied for POPC, ethanol, DOX, and SWCNT 
molecules. SWCNT surface atoms are modeled as uncharged L-J particles and ethanol and DOX 
molecular topologis with interaction parameters corresponding to CHARRM36 force field is obtained 
from Swiss Param server (http://www.swissparam.ch). In all SMD simulations, SWCNT mass center is 
attached to a dummy atom through a virtual spring with tensile force of 1000 KJ/mol (𝑁𝑚)2 and pulled 
at constant velocity of 10 nm/ns. The required pulling force is calculated by Equations (4-1) and (4-2): 




𝐾(𝑣𝑡 − (𝑟 − 𝑟0) × 𝑛)
2                                                                                                             (4-2) 
where t is current time, k is spring constant, ∇𝑈 is potential energy gradient, v is the velocity of pulling 
complex, r is the position of dummy atom, and 𝑟0 is the initial position of dummy atom. It is noteworthy 
that SWCNT is restrained by the same force constant along X and Y directions and pulled along Z 
direction perpendicular to the plane of cell membrane. 
Table 4-1. Summary of studied systems  





1 10× 10 × 25   310 
Four encapsulated DOXs inside SWCNT (20,20) and 256 
lipids solvated in a box filled with 82,633 water molecules 
2 10× 10 × 25 310 
Four encapsulated DOXs inside SWCNT (20,20) and 256 
lipids solvated in a box filled with 76,100 water molecules 
and 40 ethanol molecules in extracellular environment 
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Fig. 4-1. The component of studied system 
4. 3. Mechanism of penetration and Result 
As shown in Fig. 4-2, drug molecules are encapsulated inside the nanotube, and Fig. 4-1 (a) shows that 
at the end of equilibrium, ethanol molecules tend to be encapsulated inside nanotube, which can affect 
the adhesion strength of DOX molecules inside the nanotube. At the beginning of simulation, 10 ethanol 
molecules entered the nanotube. 
When a nanotube containing DOX molecules enters the cell membrane, as shown in Fig. 4-1 (c), a 
curvature forms on membrane surface. In this case, the hydrophobic carbon nanotube separates polar 
and hydrophilic membrane heads, preventing nanotube from entering lipid bilayer. 
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(a) (b) (c) 
   
(d) (e) (f) 
Fig. 4-2. MD snapshots of penetration mechanism of CNT containing 4 DOX molecules and 40 ethanol 
molecules randomly distributed in extracellular environment at 310 K 
Fig. 4-3 shows the force-displacement curve of CNT/DOX system penetrating lipid bilayer membrane 
in the presence and absence of ethanol molecules at extracellular solution. High force is required for the 
entry as well as exit of the molecules through membrane. The maximum amount of piercing force can 
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be seen in the first peak of force-displacement curve, at 45 nm, which is obtained for systems 1 and 2 to 
be 1200 and 1380 KJ/mol.nm, respectively, which showed that in the system with ethanol molecules, 
membrane surface was more rigid and more force was required to pierce it. Also, the time required for 
penetration in system 2 is much higher than that of system 1. After CNT enters the membrane, pull force 
for both systems is reduced to a minimum of approximately 850 KJ/mol.nm. This decrease can be 
attributed to the entry of CNT/DOX into the hydrophobic environment or hydrocarbon tails of the 
membrane. As the nanotube continues to uptake the membrane, a mutation is again seen in the amount 
of the force applied to pass through the second monolayer lipid, shown in the second peak of curve in 
Fig. 4-3. At the exit of nanotube, due to sufficient time for the nanotube to interact with cell membrane, 
a number of lipids adhere to the surface of nanotube and leave with it. It’s worth mentioning that lipid 
bilayer has self-healing property, so the membrane retains its original shape. 
 
Fig. 4-3. The force-distance curves of encapsulated DOX-SWCNT system in the absence and presence of 
ethanol molecules at velocities of 10 nm/ns 
Contact number among DOX molecules inside CNT for systems 1 and 2 is shown in Fig. 4-4. The 
number of contacts is calculated by equation (4-3): 







(𝑡))𝑑𝑟                                                                                   (4 − 3) 
where rj is the distance of DOX j
∗  from CNT i∗and NDOX and NSWCNT  are the number of drug and 
nanotube atoms, respectively,. δ is a function for calculating all contacts between drug and CNT atoms 
within 0.6 nm. 
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As was seen in Fig. 4-4, in system 2 contained ethanol molecules at extracellular moiety led to some of 
ethanol molecules were entered into the SWCNTs cavity. The average VdW energy in systems lacking 
ethanol molecules was -937.5 KJ/mol and in those containing ethanol molecules, it was equal to -881 
KJ/mol. Therefore, the existence of ethanol molecules inside SWCNTs also decreased bond strength by 
about 6%. It should be kept in mind that, at the moment of entrance and exit of nanotube through POPC, 
some hydrophilic heads of the membrane enter nanotube cavity resulting in the leak of some of the 
solution inside the nanotube and finally instability of DOX and ethanol molecules in nanotube cavity. 
Therefore, VdW energy level at the moment of the entrance (400 ps) and exit (1300 ps) of SWCNT 
carrier into and from membrane in both systems was almost similar which indicated that the presence 
of ethanol molecules at these locations had no effect. 
 
Fig. 4-4. VdW energy levels between DOX and SWCNT molecules in the presence and absence of ethanol 
molecule vs. simulation time 
Fig. 4-5 shows contact number between DOX molecules inside nanotube while penetrating the 
membrane. As shown in the figure, to the moment of entrance and exit into and from membrane, the 
number of contacts between the 4 drug molecules and SWCNT in ethanol-containing system and that in 
ethanol-free system were almost the same which also proved previous finding. By comparing Figs. 4-4 
and 4-5, it was found that contact number between drug molecules and inner surface of SWCNT were 
directly related. However, once SWCNT-DOX entered the membrane, the number of contacts was 
increased in ethanol-free system and decreased in ethanol-containing systems which resulted in the 
decrease of bonding strength between drug molecules and inner surface of SWCNT at the moment of 
entrance into the membrane. This reduction in VdW energy led to more separation possibility of drug 
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molecules from nanotube inner surface, which enhanced the interaction between drug molecules and 
caused their aggregation inside the nanotube, facilitating the release of drug molecules from nanotube. 
To do so, the number of occurred hydrogen bonds among DOX molecules while penetrating into 
cell membrane in the two considered systems were investigated. Fig. 14 shows these hydrogen bonds 
which in ethanol-containing system, DOX molecules had more hydrogen bonds from entrance to exit to 
and from the cell membrane. Therefore, it was found that the presence of ethanol molecules resulted in 
the aggregation of drug molecules inside SWCNTs. This aggregation could be due to weakened VdW 
bonds of DOX molecules with inner surface of SWCNT, which complied with the previous results. Fig. 
4-2(f) shows that ethanol molecules are able to pass intracellular environment by means of CNT. 
 
 
Fig. 4-5. Contact number among DOX molecules in the system 1 and system 2 at constant velocity of 10 nm/ns 
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Fig. 4-6. Number of hydrogen bond among DOX molecules in the systems in the presence and absence of 
ethanol molecules vs. simulation time 
Then, to more investigate and complement the obtained results, RDF results were performed 
considering center of mass of SWCNT as reference and drug molecules as particles around them. In Fig. 
4-7, it was seen that the first sharp peak occurred at radial distance r of about 1 nm for ethanol-free 
system which indicated the stability of drug molecules at this distance from the center of mass of the 
SWCNT. For system 2 which contained ethanol molecules, the following peaks occurred at distances 
1.25, 2.2 and 2.5 nm which were much weaker than peaks for system 1. It indicated the instability of 
drug molecules inside SWCNT cavity in system 2. The distance of 2.5 nm for drug molecule from 
SWCNT center indicated its presence at SWCNT terminal and its tendency to be released from the 
cavity. 
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Fig. 4-7. DOX molecule radial distribution functions (RDFs) with respect to center mass of SWCNT 
This research provided important information regarding the effects of alcohol consumption on the 
efficiency of DOX drug delivery system using SWCNTs. Also, the results obtained for the effect of the 
presence of ethanol molecules in extracellular environment on the penetrability of drug carrier provided 
critical information on the design and development of SWCNT-DOX drug delivery systems considering 
the presence of ethanol molecules in blood due to alcohol consumption which is very time-consuming 
and expensive to test in the laboratory. 
4 .4. Conclusion 
Our research showed that in the presence of ethanol molecules in extracellular environment, ethanol 
molecules have the ability to be encapsulated inside nanotube. The results of comparing the required 
pulling force also proved that in system contain ethanol molecules in extracellular, in addition to 
requirement for higher pull force, longer time was required to complete the entrance and exit through 
the membrane  .On the basis of these results, one could conclude that the presence of ethanol in 
extracellular moiety reduced the strength of VdW bonding between DOX molecules and the inner 
surface of nanotube and the possibility of the separation and release of DOX molecules at the moment 
of crossing the membrane. Also, comparison of the number of the hydrogen bonds occurred among 
DOX molecules in the two systems revealed that in ethanol-containing systems, drug molecules had 
more freedom and created more hydrogen bonds. This research provided important information on the 
effect of alcohol consumption on the efficiency of DOX drug delivery system using SWCNTs as well 
as the design and development of DOX anticancer drug delivery nanocarriers. 
 






5 .1. Concluding remarks 
Research works and key findings of this dissertation have been summarized in this chapter. 
In this work, to investigate the nature of interactions between active points of anticancer drug DOX 
and outer surfaces of pristine and functionalized CNT molecules in aqueous and gas phases using DFT 
calculations. Geometrical analyses showed that bond distance between the atoms of drug molecule 
before and after being adsorbed onto the outer surface of CNT was not significantly changed which 
indicated its stability. Negative values of adsorption energy in the investigated complexes in aqueous 
and gas phases showed that the interactions between DOX and CNT molecules were favorable and the 
process was physisorption  and exothermal. Also, the values of these energies showed that the 
functionalization of CNT, especially with –COOH functional group, improved the adsorption of drug 
molecule onto CNT and therefore, intermolecular hydrogen bonds have important role in the stability 
of physisorption. The results also showed that adsorption process was more stable and favorable in gas 
phase. QTAIM calculations showed that the nature of bonds was covalent and there was a direct relation 
between the distance and strength of bond which was even stronger in systems with functionalized 
CNTs. Also, the electronic properties and descriptors of the considered systems were calculated in 
aqueous and gas phases and the obtained results showed that the functionalization of CNTs with –COOH 
and –OH groups gave them semiconductor and metallic properties, respectively. Negative enthalpy and 
Gibbs free energy values in the studied systems indicated that adsorption process was exothermic and 
thermodynamically favorable. Also, NBO calculations showed that adsorption was achieved through 
electron transfer from drug molecule to CNT. Also, DOS results showed that, unlike pristine CNTs, 
there was not adequate hybridization between drug and CNT molecules in functionalized systems, which 
indicated stable adsorption process. 
In this work, using molecular dynamic simulation, we investigated the effects of the variations of 
environmental thermal conditions and mechanical properties of CNTs on the adsorption of DOX drug 
molecules and encapsulation ability of carbonaceous nano-carriers. The negative value of VdW energy 
suggested that the loading of DOX to the pristine SWCNT is spontaneous and exothermic and the VdW 
interaction between DOX and CNT significantly is more than EL interaction. The number of contacts 
investigated that reveal that has directly related to VdW energy for all systems. In this work, 10 different 
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systems were simulated. First, four nanotube types with different respective diameters of 21.54, 24.24, 
26.93, and 29.62 Å were selected. The obtained results showed that increase of diameter increased the 
VdW interaction and system with CNT (20, 20) had the highest encapsulation capability of DOX drug 
molecules inside cavity. In order to evaluate the effect of temperature differences on DOX adsorption 
process, 3 different temperature systems were investigated. To do so, a CNT armchair (20, 20) with 
length of 4.5 nm and equilibrium temperature of 310 K (which was equal to normothermia) was selected. 
Then, two systems with ±5 K temperature differences were simulated, and the obtained results showed 
that the human body temperature of 310 K was suitable for better drug delivery. Also, three different 
systems were tested to determine the effect of CNT length on drug adsorption process. To do so, CNTs 
armchair with chirality (20, 20) and length of 4.5 nm at 310 K were considered as a reference system, 
and two systems with similar characteristics but different lengths (of 4 nm and 5 nm) were simulated. 
The obtained results showed that the increase in CNT length had a significant effect on the adsorption 
and encapsulation of DOX molecules, and CNTs with a length of 4.5 nm was a better choice. Finally, 
to evaluate the effect of CNT chirality on DOX adsorption phenomenon, 3 different systems with 
armchair, chiral and zigzag nanotubes of (20, 20), (22, 18) and (34, 0), respectively, with similar 
diameters and lengths were simulated at 310 K. It was witnessed that chiral and especially armchair 
CNT, were far superior choices to those with zigzag structures. In addition, radial distribution plots of 
drug molecules around SWCNT, relative between intensity of peaks and adsorption has investigated. In 
this work, lower diffusion coefficient value of drug molecules was more suitable in the studied systems. 
A direct relationship was observed between FES and nanotube surface area; therefore, increase of CNT 
length and diameter is directly proportional to increased FES. This reveals greater solubility of the 
CNTs. 
      Our research showed that in the presence of ethanol molecules in extracellular environment, 
ethanol molecules have the ability to be encapsulated inside nanotube. The results of comparing the 
required pulling force also proved that in system contain ethanol molecules in extracellular, in addition 
to requirement for higher pull force, longer time was required to complete the entrance and exit through 
the membrane  .On the basis of these results, one could conclude that the presence of ethanol in 
extracellular moiety reduced the strength of VdW bonding between DOX molecules and the inner 
surface of nanotube and the possibility of the separation and release of DOX molecules at the moment 
of crossing the membrane. Also, comparison of the number of the hydrogen bonds occurred among 
DOX molecules in the two systems revealed that in ethanol-containing systems, drug molecules had 
more freedom and created more hydrogen bonds. This research provided important information on the 
effect of alcohol consumption on the efficiency of DOX drug delivery system using SWCNTs as well 
as the design and development of DOX anticancer drug delivery nanocarriers. 
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5 .2. Recommendation for Future of research 
At present, much of the research has focused on organic-inorganic hybrid nanoparticles to introduce 
better properties of nanoparticles. For example, due to the unique properties of superparamagnetic 
nanoparticles in drug delivery, surface modifications of these particles and their hybridization with one 
of the aforementioned systems such as polymers can prevent the nanoparticles from oxidizing, in 
addition to the polymer itself. Restructuring can help increase targeted drug delivery. 
In addition to the construction of hybrid particles, the creation of multifunctional structures is one of the 
growing goals of studies. For example, consider a superparamagnetic nanoparticle that has been 
hybridized with a polymer and labeled with a specific antibody or receptor. This increases the sensitivity 
and specificity of the system and greatly reduces the side effects of the drug. The distribution of these 
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